US20160374793A1 - Filter system and method - Google Patents
Filter system and method Download PDFInfo
- Publication number
- US20160374793A1 US20160374793A1 US15/257,498 US201615257498A US2016374793A1 US 20160374793 A1 US20160374793 A1 US 20160374793A1 US 201615257498 A US201615257498 A US 201615257498A US 2016374793 A1 US2016374793 A1 US 2016374793A1
- Authority
- US
- United States
- Prior art keywords
- valve
- filter
- lumen
- balloon
- expandable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A61F2002/011—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0066—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
Definitions
- the present invention relates generally to apparatus, systems, and methods for use in a lumen; and more particularly to a valve and filter apparatus, system, and method for use in the vasculature system.
- Cardiac valves can become damaged and/or diseased for a variety of reasons. Damaged and/or diseased cardiac valves are grouped according to which valve or valves are involved, and the amount of blood flow that is disrupted by the damaged and/or diseased valve. The most common cardiac valve diseases occur in the mitral and aortic valves. Diseases of the tricuspid and pulmonary valves are fairly rare.
- the aortic valve regulates the blood flow from the heart's left ventricle into the aorta.
- the aorta is the main artery that supplies oxygenated blood to the body.
- diseases of the aortic valve can have a significant impact on an individual's health. Examples of such diseases include aortic regurgitation and aortic stenosis.
- Aortic regurgitation is also called aortic insufficiency or aortic incompetence. It is a condition in which blood flows backward from a widened or weakened aortic valve into the left ventricle of the heart. In its most serious form, aortic regurgitation is caused by an infection that leaves holes in the valve leaflets. Symptoms of aortic regurgitation may not appear for years. When symptoms do appear, it is because the left ventricle must work harder relative to an uncompromised aortic valve to make up for the backflow of blood. The ventricle eventually gets larger and fluid backs up.
- Aortic stenosis is a narrowing or blockage of the aortic valve.
- Aortic stenosis occurs when the valve leaflets of the aorta become coated with deposits. The deposits change the shape of the leaflets and reduce blood flow through the valve. Again, the left ventricle has to work harder relative to an uncompromised aortic valve to make up for the reduced blood flow. Over time, the extra work can weaken the heart muscle.
- FIGS. 1A-1B illustrate an embodiment of a filter system.
- FIGS. 2A-2B illustrate another embodiment of a filter system.
- FIGS. 3A-3C illustrate another embodiment of the filter system.
- FIGS. 4A-4D illustrate another embodiment of the filter system.
- Embodiments of the present invention are directed to a filter system and method for temporary placement and use in a lumen. Embodiments of the present invention are also directed to augmenting cardiac valve function while filtering fluid moving within the lumen.
- the filter system and method can be used to temporarily replace, or augment, an incompetent valve in a body lumen and/or can be used as a temporary valve during a procedure to repair or to replace an incompetent valve with a prosthetic valve.
- Embodiments of the filter system can further include a sheath that can be used to help position the filter system within a body lumen, such as an artery or a vein, through minimally-invasive techniques.
- additional structures can be used in conjunction with the filter system.
- catheters having tissue shearing capability, stent delivery capability, and prosthetic valve delivery capability can also be used in conjunction with the filter system to aid in the replacement of a diseased native valve with a prosthetic valve.
- the sheath can include a deployment rod to extend and retract the cardiac valve and filter. After replacement or repair of a native valve, the filter system can be retracted into the lumen of the sheath.
- the filter system can be used to provide a temporary valve for replacement or repair of a diseased and/or damaged valve.
- Other embodiments can be used to provide a temporary valve and filter during a procedure to repair a diseased or damaged valve or replace a diseased and/or damaged valve with a permanent valve.
- the placement of the valve and filter apparatus within a body lumen e.g., within the aorta, adjacent the aortic valve, can help to provide for a temporary valve and filter to regulate fluid flow and filter particulate matter from fluid flowing through the aorta during transluminal cardiac valve repair and/or replacement.
- FIGS. 1A and 1B illustrate one embodiment of a filter system 100 shown in perspective view.
- Filter system 100 includes an elongate filter body 102 including an expandable filter region 150 and a valve 104 .
- FIGS. 1A and 1B provide a perspective illustration of the valve 104 of filter system 100 in an open configuration ( FIG. 1A ) and a closed configuration ( FIG. 1B ).
- the perspectives illustrated in FIGS. 1A and 1B show the filter system 100 in an expanded configuration, as will be discussed herein.
- the elongate filter body 102 defines a lumen 106 extending from a proximal end 108 towards a distal end 110 .
- the lumen 106 can be concentric with an elongate axis of the elongate filter body 102 .
- the valve 104 also defines a lumen 112 .
- the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body, where the lumen 112 of the valve 104 and the lumen 106 of the elongate filter body 102 can form a single lumen 114 .
- the lumens 106 and 112 can be contiguous so as to form the single lumen 114 .
- Other configurations are also possible.
- filter system 100 allows for both unidirectional flow of fluid and filtering of the fluid passing through the lumens 106 and 112 .
- the valve 104 includes a reversibly sealable opening 116 .
- the reversibly sealable opening 116 can be formed by one or more valve leaflets 118 .
- the valve leaflets 118 are configured to move between an open configuration (e.g., FIG. 1A , allowing fluid to flow in a first direction 193 through the lumens 106 and 112 ) and a closed configuration (e.g., FIG. 1B , preventing fluid from flowing in a second direction 197 opposite the first direction 193 ).
- the valve 104 can include any number of configurations so as to define the lumen 112 and provide the reversibly sealable opening 116 for unidirectional flow of the fluid through the lumen 112 .
- the valve 104 can include a frame 120 that supports a cover 122 .
- the cover 122 defines the reversibly sealable valve leaflets 118 that provide for the unidirectional flow of a fluid through the lumen 112 of the valve 104 .
- frame 120 includes a variety of structural configurations. Generally, the frame 120 has a curved structural configuration, as will be discussed herein.
- the frame 120 can include a first elliptical member 124 and a second elliptical member 126 , as illustrated in FIGS. 1A and 1B .
- the first elliptical member 124 and the second elliptical member 126 meet at a first region 128 and a second region 130 , where the first region 128 and the second region 130 are opposite each other across axis 132 .
- the first region 128 and the second region 130 can be located at any number of locations along the first elliptical member 124 and the second elliptical member 126 .
- the first region 128 and the second region 130 can be at or near a minor axis of the first elliptical member 124 and the second elliptical member 126 .
- the first region 128 and the second region 130 can be positioned away from the minor axis of the first elliptical member 124 and the second elliptical member 126 .
- the frame 120 can include circular members that meet at the first region 128 and the second region 130 .
- Other shapes besides elliptical and circular are also possible.
- the first elliptical member 124 and the second elliptical member 126 meet at the first region 128 and the second region 130 at an angle 134 .
- the size of angle 134 when the valve 104 is expanded can be selected based upon the type of body lumen and the body lumen size in which the valve 104 is to be placed. Additional factors include, but are not limited to, a longitudinal length 136 and a width 138 of the valve 104 . These factors, along with others discussed herein, can be used to provide the angle 134 that is sufficient to ensure that the first elliptical member 124 and the second elliptical member 126 have an appropriate expansion force against an inner wall of the body lumen in which the valve 104 is being placed.
- the valve 104 also includes a flexible joint at and/or around axis 132 that allows the valve 104 to accommodate changes in body lumen size (e.g., diameter of the body lumen) by increasing or decreasing angle 134 when the valve 104 is expanded.
- the frame 120 also has the ability to flex, as discussed herein, to allow for the distance between the first region 128 and the second region 130 to increase or decrease, thereby further accommodating changes in the body lumen size (e.g., diameter of the body lumen).
- the frame 120 also provides sufficient contact and expansion force with the surface of a body lumen wall to encourage seating of the valve 104 and to prevent retrograde flow, i.e., second direction 197 , within the body lumen.
- the frame 120 can be formed from a biocompatible metal, metal alloy, polymeric material, or combinations thereof, which allow the frame 120 to move radially between the collapsed and expanded state, as discussed herein.
- the biocompatible metal, metal alloy, or polymeric material should exhibit a low elastic modulus and a high yield stress for large elastic strains that can recover from elastic deformations.
- suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof.
- the frame 120 may be formed from a shape-memory material. Examples of a suitable shape-memory material include, but are not limited to, alloys of nickel and titanium in specific proportions known in the art as nitinol. Other materials are also possible.
- the valve 104 can further include one or more radiopaque markers 152 (e.g., tabs, sleeves, welds).
- one or more portions of the frame 120 can be formed from a radiopaque material.
- Radiopaque markers can be attached to and/or coated onto one or more locations along the frame 120 . Examples of radiopaque materials include, but are not limited to, gold, tantalum, and platinum.
- the position of the one or more radiopaque markers can be selected so as to provide information on the position, location and orientation of the valve 104 during its implantation.
- the valve 104 further includes the cover 122 .
- the cover 122 forms the valve leaflets 118 joined to valve frame 120 .
- the valve leaflets 118 can deflect between a closed configuration ( FIG. 1B ) in which retrograde fluid flow through the valve 104 is restricted, and an open configuration ( FIG. 1A ) in which antegrade fluid flow through the valve 104 is permitted.
- valve leaflets 118 of the valve are configured to open and close in response to the fluid motion and/or pressure differential across the valve leaflets 118 .
- valve 104 shown in FIGS. 1A and 1B provide embodiments in which the surfaces defining the reversibly sealable opening 116 include a first leaflet 140 and a second leaflet 142 coupled to the valve frame 120 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 104 .
- a two-leaflet configuration i.e., a bicuspid valve
- FIGS. 1A-1B of the present invention show and describe a two-leaflet configuration for valve 104
- designs employing a different number of valve leaflets e.g., tricuspid valve
- the valve leaflets 118 can have a variety of sizes and shapes.
- each of the valve leaflets 118 e.g., first leaflet 140 and second leaflet 142
- each of the valve leaflets 118 need not have valve leaflets 118 that are of a similar size and shape (i.e., the valve leaflets can have a different size and shape).
- Valve frame 120 can include an open frame construction (i.e., valve frame 120 defines an opening) through which valve leaflets 118 can radially-collapse and radially-expand.
- the valve leaflets 118 can be provided over the open frame construction of the valve frame 120 to direct fluid flow through reversibly sealable opening 116 under specific fluid flow conditions.
- the material of the valve leaflets 118 coupled to the valve frame 120 can be sufficiently thin and pliable so as to permit radially-collapsing of the valve leaflets 118 for delivery by catheter to a location within a body lumen.
- each of the valve leaflets 118 includes sufficient excess material spanning valve frame 120 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 118 forces the valve 104 into an open configuration ( FIG. 1A ).
- Valve leaflets 118 can further include arcuate edges 144 and 146 , as shown in FIG. 1A , that are positioned adjacent each other along a substantially catenary curve between the first region 128 and the second region 130 in the closed configuration ( FIG. 1B ) of valve 104 .
- arcuate edges 144 and 146 can help to define lumen 112 when the valve 104 is in the open configuration ( FIG. 1A ).
- valve frame 120 in the open configuration the sufficient excess material spanning the valve frame 120 can allow the valve leaflets 118 to take on a semi-tubular structure, as shown in FIG. 1A , when fluid pressure opens the valve 104 .
- arcuate edge 144 and 146 of valve 100 can open to approximately the full inner diameter of body lumen.
- Each of the valve leaflets 118 can further include a curve imparted thereto so as to provide a concave structure 148 to the leaflet 118 .
- the concave structure 148 allows the valve leaflets 118 to better collect retrograde fluid flow to urge valve leaflets 118 towards the closed configuration. For example, as retrograde flow begins, the valve leaflets 118 respond by moving towards the center of valve 104 . As the valve leaflets 118 approach the center of the device the valve leaflets 118 make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow.
- the valve leaflets 118 can include one or more support structures.
- the valve leaflets 118 can include one or more support ribs having a predetermined shape.
- the predetermined shape of the support ribs can include a curved bias so as to provide the valve leaflets 118 with a curved configuration.
- Support ribs can be constructed of a flexible material and have dimensions (e.g., thickness, width and length) and cross-sectional shape that allows the support ribs to be flexible when valve leaflets 118 are urged into an open position, and stiff when the valve leaflets 118 are urged into a closed position upon experiencing sufficient back flow pressure from the direction downstream from the valve.
- support ribs can also be attached to valve frame 120 so as to impart a spring bias to the valve leaflets in either the open or the closed configuration.
- the valve leaflets 118 can be constructed of a fluid-impermeable biocompatible material that can be either synthetic or biologic.
- Possible synthetic materials include, but are not limited to, expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, polyethlylene (PE), polyethylene terephthalate (PET), silk, urethane, Rayon, Silicone, or the like.
- Possible biologic materials include, but are not limited to allogeneic or xenograft material. These include explanted veins and decellularized basement membrane materials, such as small intestine submucosa (SIS) or umbilical vein.
- Valve leaflets 118 can be coupled to the various embodiments of valve frame 120 , as described herein, in any number of ways.
- a variety of fasteners can be used to couple the material of the valve leaflets 118 to the valve frame 120 .
- Fasteners can include, but are not limited to, biocompatible staples, glues, and sutures.
- the material of the valve leaflets 118 can be wrapped at least partially around the valve frame 120 and coupled using the fastener.
- valve leaflets 118 can be coupled to the various embodiments of valve frame 120 through the use of heat sealing, solvent bonding, adhesive bonding, or welding the valve leaflets 118 to either a portion of the valve leaflet 118 (i.e., itself) and/or the valve frame 120 .
- Valve leaflets 118 can also be attached to valve frame 120 according to the methods described in U.S. Patent Application Publication 2002/0178570 to Sogard et al., which is hereby incorporated by reference in its entirety.
- valve 104 can include three leaflets, with the various frames and covering configurations as described herein. Further, valve 104 can be configured to extend proximally and distally in a curvilinear manner to accommodate the coronary ostia and the diseased valve. For example, leaflets can extend past the coronary ostia in the central portion of the leaflets, and extend to accommodate the attachment points of the diseased valve by incorporating a tri-lobar saddle shaped configuration. In one embodiment, the valve 104 can include a configuration that allows the valve 104 to be place functionally distal to the coronary ostia for proper coronary perfusion, while maintaining sufficient clearance for the diseased valve and the repair or replacement of the diseased valve to be performed.
- valve 104 Examples of a three leaflet valve suitable for use as valve 104 are illustrated in U.S. patent application Ser. No. 11/107,162, entitled “Valve Apparatus, System and Method”, and U.S. patent application Ser. No. 10/933,088, entitled “Cardiac Valve, System, and Method”, which is hereby incorporated by reference in its entirety.
- a portion of the elongate filter body 102 can include an expandable filter region 150 to filter the unidirectional flow of the fluid moving through the valve 104 .
- filtering of fluid can be accomplished through use of the expandable filter region 150 by trapping and/or inhibiting the passage of particular matter released into and/or present in the fluid moving through the valve 104 . Trapped particulate matter can then be removed with the filter system 100 through the lumen 106 .
- the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body 102 .
- the frame 120 of the valve 104 can be coupled to the expandable filter region 150 proximal the distal end 110 of the elongate filter body 102 .
- Methods of coupling the frame 120 to the expandable filter region 150 of the elongate filter body 102 can be as described herein for coupling the valve leaflets 118 to the frame 120 .
- the expandable filter region 150 can move between a first configuration (e.g., a compressed state, shown in FIG. 3A ) and a second configuration (e.g., an expanded state, shown in FIGS. 1A-1B and FIGS. 2A-2B ).
- the expandable filter region 150 can expand from the first configuration to the second configuration due to force imparted by the frame 120 as it expands.
- the expandable filter region 150 can expand from the first configuration to the second configuration by a combination of force imparted by the frame 120 as it expands and under pressure of the unidirectional flow of the fluid.
- the force imparted by the frame when the valve is in the open configuration can help to maintain the expandable filter region expanded when under retrograde fluid flow, such as when the valve is in a closed configuration.
- the expandable filter region 150 can be configured to radially self-expand when released from a compressed state.
- the expandable filter region 150 in its deployed state can fill the cross-section area of the lumen in which the expandable filter region 150 and valve 104 are deployed.
- filter region 150 in its deployed state can apply sufficient pressure to the inner wall of the lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 150 and the surface of the lumen wall.
- the valve frame 120 can be used at least in part to apply the sufficient pressure to the inner wall of the body lumen.
- the area and shape defined by the expandable filter region 150 e.g., the diameter of the expandable filter region
- the area and shape defined by the expandable filter region 150 in its deployed state can be dependent upon the location in which the apparatus is intended to be used.
- expandable filter region 150 examples include those having a woven, braided and/or a knit configuration as the same will be known and understood by one of ordinary skill in the art.
- the expandable filter regions 150 can be formed of a material having pores formed therein or imparted thereto.
- the expandable filter regions 150 can be formed of a number of materials. Materials can include polymers, such as ePTFE, PTFE, polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, PE, PET, silk, urethane, Rayon, Silicone, polyamid, mixtures, and block co-polymers thereof.
- expandable filter region 150 can be configured to reduce passage of potentially injurious emboli to arteries feeding the brain, heart, kidneys, and other tissues and organs.
- expandable filter region 150 can help to reduce or prevent passage of emboli greater than about 5 to 1000 micrometers in cross-sectional size.
- Expandable filter region 150 may also prevent passage of emboli larger than 50 to 200 micrometers in cross-sectional size.
- Multiple regions or layers of expandable filter region 150 may be incorporated to more efficiently filter emboli, such as a 200 micrometer portion of the expandable filter region 150 to capture larger particles and a 75 micrometer portion of the expandable filter region 150 to capture smaller particles.
- expandable filter region 150 include the radially self-expanding configurations formed from temperature-sensitive memory alloy which changes shape at a designated temperature or temperature range. Examples of such materials include, but are not limited to, nitinol and nitinol-type metal alloys.
- self-expanding configurations for the expandable filter region 150 include those having a spring-bias imparted into the members forming the filter region 150 .
- the expandable filter region 150 can have a woven, braided and/or a knit configuration that can also impart a self-expanding aspect to the expandable filter region 150 .
- the filter region 150 can further include radiopaque markers 152 .
- radiopaque markers e.g., attached or coated
- Other portions of filter system 100 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the filter system 100 .
- the elongate filter body 102 can further include a fluid tight plug 154 positioned within the lumen 106 of the elongate filter body 102 .
- the fluid tight plug 154 can be positioned proximal the expandable filter region 150 so as to occlude the lumen 106 , thereby directing the unidirectional flow of the fluid from the lumen 106 through the expandable filter region 150 .
- the fluid tight plug 154 can have a variety of shapes and configurations.
- a first end 155 and a second end 157 of the fluid tight plug 154 can include a flat planar surface.
- the first end 155 of the fluid tight plug can include a conical configuration, as shown in FIGS. 1A and 1B .
- Other shapes and configurations for the fluid tight plug 154 are also possible.
- FIGS. 2A and 2B illustrate an additional embodiment of a filter system 200 .
- FIGS. 2A and 2B provide a perspective illustration of the filter system 200 that includes both the elongate filter body 202 , as described herein, and the valve 204 .
- the valve 204 includes a frame 220 and a cover 222 , including valve leaflets 240 and 242 (shown in FIG. 2A ), having a different configuration as compared to the valve 104 described above in FIGS. 1A and 1B .
- valve 204 is illustrated in U.S. patent application Ser. No. 10/741,992, entitled “Venous Valve Apparatus, System, and Method”, which is hereby incorporated by reference in its entirety.
- the frame 220 of valve 204 includes an outer surface 256 and an inner surface 258 opposite the outer surface 256 .
- the inner surface 258 defines the lumen 212 of the valve 204 for passing fluid therethrough.
- the frame 220 also includes a first end 262 and a second end 260 .
- the cover 222 can be located over at least the outer surface 256 of the frame 220 .
- the cover 222 can extend around a perimeter of the frame 220 so as to completely cover the outer surface 256 of the frame 220 .
- the cover 222 extends over the outer surface of the frame 220 so that there are no exposed portions of the outer surface 256 of the frame 220 .
- the cover 222 can also be located over at least the inner surface 258 of the frame 220 .
- a further embodiment includes the cover 222 located over at least the outer surface 256 and the inner surface 258 .
- the frame 220 can include an open frame configuration that includes a first vertex 263 and a second vertex 264 relative the second end 260 of the frame 220 .
- Frame 220 can further include a first valley 266 and a second valley 268 adjacent the second end 260 relative the first vertex 263 and the second vertex 264 .
- the first vertex 263 and the second vertex 264 can be positioned opposite each other along a common axis 270 (shown in FIG. 2B ).
- FIGS. 2A and 2B also illustrate that the first valley 266 and the second valley 268 can be positioned opposite each other and perpendicular to axis 270 .
- first and second vertex 263 and 264 and the first and second valley 266 and 268 are also possible.
- more than two vertexes and valleys may be included in the embodiments.
- three valve leaflets e.g., a tricuspid valve
- three vertexes and three valleys can also be included to help form the three leaflets.
- the cover 222 can further include valve leaflets 240 and 242 that define the reversibly sealable opening 216 for the unidirectional flow of the fluid through the lumen 212 .
- the surfaces of the cover 222 can be deflectable between a closed configuration ( FIG. 2B ) in which fluid flow through the lumen 212 can be restricted and an open configuration ( FIG. 2A ) in which fluid flow through the lumen 212 can be permitted in response to the fluid motion and/or pressure differential across the valve leaflets 240 and 242 .
- valve 204 shown in FIGS. 2A and 2B provide embodiments in which the surfaces defining the reversibly sealable opening 216 include the first leaflet 240 and the second leaflet 242 coupled to the valve frame 220 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 204 .
- a two-leaflet configuration i.e., a bicuspid valve
- FIGS. 2A and 2B of the present invention show and describe a two-leaflet configuration for valve 204 , designs employing a different number of valve leaflets (e.g., tricuspid valve) are also possible.
- each of the valve leaflets 240 and 242 include sufficient excess material spanning valve frame 220 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 240 and 242 forces the valve 204 into an open configuration ( FIG. 2A ).
- Valve leaflets 240 and 242 further include arcuate edges, as illustrated in FIGS. 1A and 1B and shown as 144 and 146 , that are positioned adjacent each other along a substantially catenary curve between the first vertex 263 and the second vertex 264 in the closed configuration ( Figure B) of valve 204 .
- arcuate edges 244 and 246 can help to define lumen 212 when the valve 204 is in the open configuration ( FIG. 2A ).
- valve leaflets 240 and 242 in the open configuration can allow the valve leaflets 240 and 242 to take on a semi-tubular structure, as shown in FIG. 2A , when fluid pressure opens the valve 204 .
- arcuate edge 244 and 246 of valve 204 can open to approximately the full inner diameter of body lumen.
- Each of the valve leaflets 240 and 242 can further include a curve imparted thereto so as to provide a concave structure to the leaflet 240 and 242 .
- the concave structure allows the valve leaflets 240 and 242 to better collect retrograde fluid flow to urge valve leaflets 240 and 242 towards the closed configuration ( FIG. 2B ).
- the valve leaflets 240 and 242 respond by moving towards the center of valve 204 .
- the valve leaflets 240 and 242 can make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow, i.e., second direction 197 as shown in FIGS. 1A and 1B .
- FIGS. 3A and 3B provide a further illustration of the filter system 300 (i.e., the elongate filter body 302 , valve 304 , and filter region 350 ) that includes a sheath 374 having a lumen 376 .
- FIGS. 3A and 3B provide a sectional illustration of the filter system 300 at least partially contained within a lumen 376 of the sheath 374 ( FIG. 3A ) and of the filter system 300 at least partially deployed from the lumen 376 of the sheath 374 ( FIG. 3B ).
- both the valve 304 and the filter region 350 of the elongate filter body 302 can be releasably positioned in a coaxial arrangement within the lumen 376 of the sheath 374 .
- the configuration of the support frame 320 provides the valve 304 with sufficient flexibility to move between the first configuration 342 (e.g., a retracted state within the lumen 376 of the sheath 374 as shown in FIG. 3A ) and the second configuration 344 (e.g., an extended state outside the lumen 376 of the sheath 374 as shown in FIG. 3B ).
- the valve 304 can be configured to reside in the compressed state when retracted within the lumen 376 of the sheath 374 , as illustrated in FIG. 3A , and in an expanded state when extended from the lumen 376 of the sheath 374 , as illustrated in FIG. 3B . In one embodiment, the valve 304 expands from its compressed state within the lumen 376 to the deployed state when the sheath 374 is retracted from around the valve 304 .
- the sheath 374 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof.
- the sheath 374 can have a wall thickness and an inner diameter sufficient to maintain both the valve 304 and the expandable filter region 350 in the retracted state when they are positioned within the lumen 376 .
- the sheath 374 can further include radiopaque markers 352 .
- radiopaque markers e.g., attached or coated
- the support frame 320 of the cardiac valve 304 expands to increase the diameter 312 of the lumen 306 of the valve 304 as the valve 304 is extended from the sheath 374 .
- the diameter 312 of the lumen 306 can be determined based upon the type of body lumen and the body lumen size in which the valve 304 is to be placed. In an additional example, there can also be a minimum value for the width for the support frame 320 that ensures that the valve 304 will have an appropriate expansion force against the inner wall of the body lumen to prevent retrograde flow within the body lumen.
- the lumen 306 of the elongate filter body 302 in the filter region 350 also increases in diameter as the valve 304 and the elongate filter body 302 are extended from the sheath 374 .
- the expandable filter region 350 can expand from the first configuration to the second configuration due in part to force imparted by the frame 320 as it expands and under pressure of the unidirectional flow of the fluid.
- the expandable filter region 350 can be configured to radially self-expand, as the same has been described herein, when released from its compressed state within the lumen 376 of the sheath 374 .
- the expandable filter region 350 in its deployed state can fill the cross-section area of a body lumen in which the valve 304 and expandable filter region 350 are deployed.
- filter region 350 in its deployed state can apply sufficient pressure to the inner wall of the body lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 350 and the surface of the body lumen wall.
- the area and shape defined by the expandable filter region 350 e.g., the diameter of the expandable filter in its deployed state will be dependent upon the location in which the filter system is intended to be used.
- the filter system 300 can be extended and retracted from the lumen 376 of the sheath 374 in any number of ways.
- the elongate filter body 302 can be pulled longitudinally within the lumen 376 of the sheath 374 so as to retract the valve 304 and the filter region 350 of the elongate filter body 302 .
- the elongate filter body 302 supported by the sheath 374 , provides sufficient column strength to allow force imparted at the proximal end 308 of the elongate filter body 302 to retract the valve 304 and the filter region 350 .
- a portion of the elongate filter body 302 extending from the filter region 350 to the proximal end 308 can be reinforced and/or have an alternative construction relative the filter region 350 so as to impart sufficient column strength to the elongate filter body 302 .
- the elongate filter body 302 can then be pushed longitudinally within the lumen 376 of the sheath 374 so as to extend the valve 304 and the filter region 350 of the elongate filter body 302 .
- valve 304 and the filter region 350 can be deployed and retracted by moving the sheath 374 relative the elongate filter body 302 .
- the elongate filter body 302 can be held while the sheath 374 is moved longitudinally so as to either deploy or retract the valve 304 and the filter region 350 .
- the filter system 300 and the sheath 374 can further include handles positioned at the proximal end 308 of the elongate filter body 302 and a first sheath end 378 of the sheath 374 .
- the sheath 374 includes a handle 382 and the elongate filter body 302 includes a handle 384 .
- Handles 382 and 384 allow the sheath 374 and the elongate filter body 302 to move relative to each other so as to extend and/or retract the valve and a portion of the elongate filter body from the lumen 376 of the sheath 374 .
- the distance between the handles 382 and 384 can correspond approximately to the length of the compacted valve 304 and the filter region 350 to effectively deploy the expandable filter region 350 and valve 304 .
- Other configurations and relational lengths are possible.
- filter system 300 and the sheath 374 can further include a sleeve 386 having a slit 388 and a pull tab 390 positioned between the handles during delivery to prevent inadvertent exposure of the valve 304 and filter region 350 .
- the sleeve 386 can be stripped from the filter system 300 by pulling the pull tab once the sheath 374 has been placed at the predetermined location at which the valve 304 and the filter region 350 are to be deployed.
- Other removable structures for preventing inadvertent exposure of the valve 304 and filter region 350 are also possible.
- the filter system 300 can be extended and/or retracted from the sheath 374 through the use of a deployment rod 394 .
- the deployment rod 394 extends from the proximal end 308 of the elongate filter body 302 through the lumen 376 to the fluid tight plug 354 , as the same has been described in connection with FIGS. 1A and 1B .
- the deployment rod 394 can be used to move the elongate filter body 302 and the valve 304 relative the sheath 374 .
- the deployment rod 394 can extend through the lumen 312 to the fluid tight plug 354 , where the deployment rod 394 can be used to push the filter system 300 relative the sheath 374 to deploy the valve 304 and the filter region 350 and/or pull the filter system 300 relative the sheath 374 to draw the valve 304 and the filter region 350 back into its compressed state within the lumen 376 of the sheath 374 .
- the deployment rod 394 can be used to change the position of the valve 304 and filter region 350 once deployed from a first position within the lumen to a second position.
- the deployment rod 394 and the fluid tight plug 354 can further include releasably interconnecting members to allow the deployment rod 394 and the fluid tight plug 354 to be separated.
- the fluid tight plug 354 can include a socket having threads to receive and interact with a threaded portion of the deployment rod 394 . This structure allows for the deployment rod 394 to be inserted through the lumen 376 of the elongate filter body 302 to the fluid tight plug 354 , where the treaded portion of the deployment rod 394 can be screwed into the threaded socket of the fluid tight plug 354 .
- the deployment rod 394 can then be removed from the lumen 376 by unscrewing the threaded portion of the deployment rod 394 from the threaded socket of the fluid tight plug 354 .
- other ways of decoupling the deployment rod 394 and the fluid tight plug 354 are also possible.
- the deployment rod 394 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof.
- the deployment rod 394 can be formed of medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof.
- FIGS. 4A-4D provides a further illustration of the filter system 400 that includes the sheath 474 , as previously discussed, and a catheter 401 and an apparatus 445 .
- FIGS. 4A-4D provide perspective illustrations of the filter system 400 at least partially contained within the lumen 476 of the sheath 474 , with the catheter 401 and the apparatus 445 at least partially contained within a lumen 406 of the elongate filter body 402 .
- the catheter 401 includes an elongate body 403 having a first lumen 405 extending between a proximal end 407 and a distal end 409 .
- the first lumen 405 allows for additional elongate members to travel along a longitudinal axis of the elongate body 402 .
- the catheter 401 further includes a first cutting head 411 having a blade 413 and an elongate pulling member 415 .
- the first cutting head 411 can be positioned adjacent the distal end 409 of the elongate body 403 of the catheter 401 with the elongate pulling member 415 extending through the first lumen 405 .
- the elongate pulling member 415 can slide within the first lumen 405 to move the first cutting head 411 relative the distal end 409 of the elongate body 403 of the catheter 401 .
- the catheter 401 also includes a second cutting head 417 having a blade 419 .
- the second cutting head 417 can be positioned adjacent the distal end 409 of the elongate body 403 between the distal end 409 and the first cutting head 411 .
- the blade 413 of the first cutting head 411 can move relative the blade 419 of the second cutting head 417 to provide a shearing action.
- the shearing action can be sufficient for cutting cardiac tissue.
- FIG. 4A further illustrates an embodiment in which the second cutting head includes an elongate pushing member 421 .
- the elongate pushing member 421 can slide within the first lumen 405 to move the second cutting head 417 relative the distal end 409 of the elongate body 403 and the first cutting head 411 .
- the elongate pulling member 415 can be arranged concentrically with the elongate pushing member 421 in the first lumen 405 .
- the elongate pulling member 415 , the elongate pushing member 421 and the first lumen 405 of the elongate body 403 can be positioned coaxially.
- the lumen 405 has a diameter sufficient to accommodate the elongate pushing member 421 .
- the elongate pushing member 421 had a diameter sufficient to accommodate the elongate pulling member 415 .
- the elongate pulling member 415 and the elongate pushing member 421 can be structured such that their relative rotational movement is restricted.
- relative axial rotation of the elongate pulling member 415 and the elongate pushing member 421 is restricted due to the structure of the members 415 and 421 .
- this can be accomplished using one or more physical structures formed in and/or attached to the members 415 and 421 .
- one of the members 415 or 421 can include a channel through which an extension from the other of the members 415 or 421 can travel so as to inhibit axial rotation of the members 415 and 421 .
- the members 415 and 421 could have a cross-sectional shape that inhibits relative axial rotation. Examples of such cross-sectional shapes include oval or elliptical cross-sectional shapes. Other shapes are also possible.
- a gap can exist between the opposing surfaces of the first lumen 405 and the elongate pushing member 421 to allow the elongate pushing member 421 to move through the first lumen 405 from force applied at the proximal end of the elongate pushing member 421 .
- a gap can exist between the opposing surfaces of the elongate pushing member 421 and the elongate pulling member 415 to allow the elongate pushing member 421 and the elongate pulling member 415 to move relative each other from force applied at the proximal end of the elongate pushing member 421 and/or the elongate pulling member 415 .
- the elongate pull member 415 can further include a lumen 471 for tracking over a guidewire.
- a lubricant can be included on the surfaces of the elongate pulling member 415 , the elongate pushing member 421 and the first lumen 405 .
- the first cutting head 411 further includes a shape conducive to passing the catheter 401 and the filter system 400 through a body lumen (e.g., a lumen of the cardiovascular system).
- a body lumen e.g., a lumen of the cardiovascular system.
- the first cutting head 411 can include a conical shape having a first end 423 and a second end 425 , where the first end 423 has a diameter that is less than a diameter of the second end 425 .
- Other shapes are also possible.
- the shape of the first cutting head 411 can be configured to protectively house the blade 413 from structures passing by the first end 423 towards the second end 425 .
- the shape of the first cutting head 411 can be used to shield the blade 413 from unintentionally interfering and/or cutting tissue within a body lumen.
- the blade 413 can be radially positioned relative the elongate pulling member 415 generally along the second end 425 of the first cutting head 411 .
- the first cutting head 411 can include more than one blade 413 .
- Each blade 413 and 419 further includes a cutting edge 427 and 429 , respectively, in alignment so as to provide shearing action between a pair of the cutting edges 427 and 429 of the blades 413 and 419 .
- the first cutting head 411 can move relative the second cutting head 417 to allow the cutting edge 427 of the blade 413 of the first cutting head 411 to slide past the cutting edge 429 of the blade 417 of the second cutting head 417 .
- suitable materials for the blades 413 and 419 include, but are not limited to, stainless steel (e.g., 316L) and titanium.
- blades 413 and 419 can be secured to the first cutting head 411 and the second cutting head 417 , respectively, in any number of ways.
- blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of mechanical fasteners, such as screws, and/or interlocking pins and sockets.
- blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of chemical adhesives. Examples of such chemical adhesives include, but are not limited to, medical grade adhesives such as cyanoacrylate, acrylic, silicone, and urethane adhesives.
- the first cutting head 411 can be configured to receive and house at least a portion of the second cutting head 417 , including the blade 419 , such that the second blade 419 does not pass beyond the first cutting head 411 .
- the first cutting head can include a socket that extends radially relative the elongate pulling member 415 and distally from the blade 413 to receive the blade 419 of the second cutting head 417 as the blade 419 passes the blade 413 .
- the blade 419 can be positioned within the socket of the first cutting head 411 as the catheter 401 is moved through a lumen.
- Catheter 401 can have various lengths between the proximal end 407 and the first cutting head 411 .
- the length between the proximal end 407 and the first cutting head 411 is sufficient to allow the catheter 401 to be percutaneously implanted through a patient's vasculature to position the cutting heads (e.g., the first and second cutting heads) at a predetermined location.
- the predetermined locations include, but are not limited to, cardiovascular locations such as on or adjacent to a cardiac valve of the heart (e.g., the aortic valve), including within a chamber of the patient's heart (e.g., the left ventricle of the heart).
- the length between the proximal end 407 and the first cutting head 411 will be dependent upon each patient's physiological structure and the predetermined location within the patient.
- the elongate body 403 of the catheter 401 , the elongate pulling member 415 , the elongate pushing member 421 , the second cutting head 417 and the first cutting head 411 can be formed from a wide variety of materials and in a wide variety of configurations.
- the materials may include, but are not limited to, one or more of polyvinyl chloride (PVC), polyethylene (PE), polyolefin copolymer (POC), polyethylene terephthalate (PET), polyamid, mixtures, and block co-polymers thereof.
- the materials may include one or more alloys in any number of configurations.
- the materials may include stainless steel (e.g., 316L), titanium, or other medical grade alloys as are known. These materials may also have a woven configuration or a solid extruded configuration.
- the selection of material and configuration allows for the elongate body 403 , the elongate pulling member 415 , the elongate pushing member 421 , the second cutting head 417 and the first cutting head 411 to each have the flexibility, and the ability to be either pushed and/or pulled thereby accomplishing the actions described for the components herein.
- selection of the material can be based generally on a broad range of technical properties, including, but not limited to, modulus of elasticity, flexural modulus, and Shore A hardness required for the embodiments of the present invention.
- Components of the present apparatus and/or system can also be coated for lubrication, for abrasion resistance, or to deliver an anticoagulatory drug.
- first cutting head 411 and second cutting head 417 can be accomplished by alternate cutting, shearing, slicing, grinding or ablative means as are known for other purposes.
- thermal energy can be used to weaken or slice the diseased valve, rolling cutters could be incorporated, or a “cutting balloon” mechanism could be incorporated.
- the catheter 401 can further include radiopaque markers 431 .
- radiopaque markers e.g., attached or coated
- radiopaque markers can be used to mark the location of blades 413 and 419 .
- Other portions of catheter 401 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the catheter 401 .
- catheter 401 can reside at least partially within the lumen 406 of the elongate filter body.
- FIG. 4B provides an example in which both the valve 404 and the filter region 450 have been extended from the sheath 474 , as discussed herein, with the catheter 401 at least partially extending distally from the valve 404 .
- the valve leaflets of valve 404 can seat around the elongate body 403 of the catheter 401 to provide the reversibly sealable opening of the valve 404 .
- the elongate body 403 can travel longitudinally within the lumen 406 of the elongate filter body 402 to extend and retract the distal end 409 of the catheter 401 relative the valve 404 of the filter system 400 .
- the elongate filter body 402 can further include a sealing ring that allows the elongate body 403 of the catheter 401 to move longitudinally while maintaining a fluid tight seal within the lumen 406 of the elongate filter body 402 .
- the elongate body 403 of catheter 401 further includes a second lumen 435 , as shown in FIG. 4A .
- the second lumen 435 can extend between the proximal end 407 and the distal end 409 of the elongate body 403 , where the second lumen 435 can be coupled in fluid tight communication to an inflatable balloon 437 on the elongate body 403 .
- the catheter 401 can further include an inflation device 495 that can reversibly couple in fluid tight communication with the second lumen 435 to provide fluid pressure to inflate and deflate balloon 437 .
- the inflatable balloon 437 can be positioned adjacent the distal end 409 of the elongate body 403 and proximal to the second cutting head 417 .
- the inflatable balloon 437 can be inflated from a deflated state to an inflated state by pressure applied by fluid moving through the second lumen 435 .
- the catheter 401 further includes an expandable stent 439 positioned over at least a portion of the inflatable balloon 437 .
- the expandable stent 439 can move between a compressed state, as shown in FIG. 4B , and an expanded state, as shown in FIG. 4C , using the inflatable balloon 437 .
- the expandable stent 439 can be deployed over cardiac tissue sheared using the first and second cutting heads 411 and 417 using the inflatable balloon 437 .
- Catheter 401 can further include an annular push ring 441 positioned between the second cutting head 417 and the inflatable balloon 437 .
- the annular push ring 441 can be used for contacting and moving at least a portion of cardiac tissue sheared with the first and second cutting heads 411 and 417 .
- the first and second cutting heads 411 and 417 can be used to shear cardiac tissue (e.g., one or more cusps of a valve).
- the annular push ring 441 can then be advanced into contact with the sheared cardiac tissue. As the annular push ring 441 advances the sheared cardiac tissue can be directed towards the wall of the lumen.
- Stent 439 can then be positioned over at least a portion of the sheared cardiac tissue positioned using the annular push ring 441 . Stent 439 can then be deployed using the inflatable balloon 437 to position at least a portion of the sheared cardiac tissue between the expanded stent 439 and the wall of the lumen. As will be appreciated, the dimensions and physical characteristics of the stent 439 will be dependent upon the location in which the stent 439 is to be implanted.
- the apparatus 445 can further include a cardiac valve 455 .
- the cardiac valve 455 can be releasably positioned adjacent the expandable stent 439 over at least a portion of the inflatable balloon 437 .
- cardiac valve 455 can be implanted within the fluid passageway of a body lumen, such as for replacement of a valve structure within the body lumen to regulate the flow of a bodily fluid through the body lumen in a single direction.
- the cardiac valve 455 can be configured to reside in a compressed state over at least a portion of the inflatable balloon 437 . Using the inflatable balloon, the cardiac valve 455 can be expanded into a deployed state as illustrated in FIGS. 4C and 4D .
- cardiac valve 455 includes valve 204 as described herein.
- An additional embodiment of cardiac valve 455 is illustrated in U.S. patent application Ser. No. 11/049,000, entitled “Vascular Catheter, System, and Method, which is hereby incorporated by reference in its entirety.
- the cardiac valve 455 includes a support frame and a cover.
- the cover of the cardiac valve 455 can be positioned over at least the outer surface of the support frame.
- the cover includes surfaces defining a reversibly sealable opening for unidirectional flow of a liquid through the lumen of the cardiac valve 455 .
- the filter system 400 , catheter 401 and the apparatus 445 can further include handles to allow the various components to be moved relative each other.
- handles 479 can allow the elongate pushing member 421 and/or the elongate pulling member 415 to be moved relative each other.
- Handle 481 can allow the catheter 401 to be moved relative the apparatus 445 and the sheath 474 .
- handles 483 can allow the sheath 474 and the filter system 400 to be moved relative each other.
- other structures may be used in place of or in addition to the handles to allow the various components of the filter system 400 , catheter 401 , and apparatus 445 to move relative each other.
- embodiments of the present invention further include methods for forming the filter system and apparatus, as discussed herein.
- embodiments of the present invention can be formed by providing an elongate filter body that includes the expandable filter region defining a lumen.
- the valve can further be provided, where the valve can be adjoined proximal the distal end of the elongate filter body to form a single lumen through which fluid flows unidirectionally through the valve and the elongate filter body to filter the fluid.
- the valve can define a reversibly sealable opening for the unidirectional flow of fluid through the lumen of the valve.
- the expandable filter region can be configured to move between a first configuration and a second configuration. In one embodiment, the movement from the first configuration to the second configuration can occur as the valve expands in addition to under pressure of the unidirectional flow of the fluid.
- the elongate filter body can also be provided with the fluid tight plug to direct the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid.
- the fluid tight plug can include various shapes and sizes and can be positioned according to the embodiments described herein.
- the valve can be provided with a support frame having various configurations.
- a first configuration can include a compressed configuration and a second configuration can include an expanded configuration.
- expansion of the support frame can be supplemented by fluid flowing into the lumen of the elongate filter body.
- the filter system and apparatus can further include providing the catheter having the first cutting head and the second cutting head, as discussed herein.
- the first cutting head can include the blade and the elongate pulling member, where the first cutting head can be positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen of the catheter. The elongate pulling member can then slides within the first lumen to move the first cutting head relative the distal end of the elongate body.
- the second cutting head can also include a blade, and be positioned adjacent the distal end of the elongate body between the distal end and the first cutting head. The blade of the first cutting head can be moved relative the blade of the second cutting head to provide the shearing action for cardiac tissue.
- the catheter extends though the lumen of the elongate filter body and the lumen of the valve.
- the filter system and apparatus further include providing a second lumen to the elongate body, where the second lumen can be in fluid tight communication with the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head.
- the expandable stent can then be positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue.
- the annular push ring can also be provided between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue.
- the embodiments can also include providing the cardiac valve positioned over the inflatable balloon, where the cardiac valve can be deployed through the use of the inflatable balloon.
- the support frame 120 and/or the cover 122 can be coated with a non-thrombogenic biocompatible material, as are known or will be known.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
Abstract
A filter system, comprising an elongate filter body defining a lumen and having a proximal end and a distal end. A valve can be provided defining a lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the lumen. The valve can be adjoined proximal the distal end of the elongate filter body, wherein the elongate filter body filters the unidirectional flow of the fluid passing through the lumen of the valve and the lumen of the elongate filter body.
Description
- This application is a continuation of U.S. application Ser. No. 14/604,125, filed Jan. 23, 2015, which is a continuation of U.S. application Ser. No. 11/049,019, filed Feb. 1, 2005.
- The present invention relates generally to apparatus, systems, and methods for use in a lumen; and more particularly to a valve and filter apparatus, system, and method for use in the vasculature system.
- Cardiac valves can become damaged and/or diseased for a variety of reasons. Damaged and/or diseased cardiac valves are grouped according to which valve or valves are involved, and the amount of blood flow that is disrupted by the damaged and/or diseased valve. The most common cardiac valve diseases occur in the mitral and aortic valves. Diseases of the tricuspid and pulmonary valves are fairly rare.
- The aortic valve regulates the blood flow from the heart's left ventricle into the aorta. The aorta is the main artery that supplies oxygenated blood to the body. As a result, diseases of the aortic valve can have a significant impact on an individual's health. Examples of such diseases include aortic regurgitation and aortic stenosis.
- Aortic regurgitation is also called aortic insufficiency or aortic incompetence. It is a condition in which blood flows backward from a widened or weakened aortic valve into the left ventricle of the heart. In its most serious form, aortic regurgitation is caused by an infection that leaves holes in the valve leaflets. Symptoms of aortic regurgitation may not appear for years. When symptoms do appear, it is because the left ventricle must work harder relative to an uncompromised aortic valve to make up for the backflow of blood. The ventricle eventually gets larger and fluid backs up.
- Aortic stenosis is a narrowing or blockage of the aortic valve. Aortic stenosis occurs when the valve leaflets of the aorta become coated with deposits. The deposits change the shape of the leaflets and reduce blood flow through the valve. Again, the left ventricle has to work harder relative to an uncompromised aortic valve to make up for the reduced blood flow. Over time, the extra work can weaken the heart muscle.
-
FIGS. 1A-1B illustrate an embodiment of a filter system. -
FIGS. 2A-2B illustrate another embodiment of a filter system. -
FIGS. 3A-3C illustrate another embodiment of the filter system. -
FIGS. 4A-4D illustrate another embodiment of the filter system. - Embodiments of the present invention are directed to a filter system and method for temporary placement and use in a lumen. Embodiments of the present invention are also directed to augmenting cardiac valve function while filtering fluid moving within the lumen. For example, the filter system and method can be used to temporarily replace, or augment, an incompetent valve in a body lumen and/or can be used as a temporary valve during a procedure to repair or to replace an incompetent valve with a prosthetic valve.
- Embodiments of the filter system can further include a sheath that can be used to help position the filter system within a body lumen, such as an artery or a vein, through minimally-invasive techniques. In further embodiments, additional structures can be used in conjunction with the filter system. For example, catheters having tissue shearing capability, stent delivery capability, and prosthetic valve delivery capability can also be used in conjunction with the filter system to aid in the replacement of a diseased native valve with a prosthetic valve. In an additional embodiment, the sheath can include a deployment rod to extend and retract the cardiac valve and filter. After replacement or repair of a native valve, the filter system can be retracted into the lumen of the sheath.
- The Figures herein follow a numbering convention in which the first digit or digits correspond to the drawing Figure number and the remaining digits identify an element or component in the drawing. Similar elements or components between different Figures may be identified by the use of similar digits. For example, 110 may reference element “10” in
FIG. 1 , and a similar element may be referenced as 210 inFIG. 2 . As will be appreciated, elements shown in the various embodiments herein can be added, exchanged, and/or eliminated so as to provide any number of additional embodiments of the filter system. In addition, the elements shown in the various embodiments are not necessarily to scale. - Various embodiments of the invention are illustrated in the figures. Generally, the filter system can be used to provide a temporary valve for replacement or repair of a diseased and/or damaged valve. Other embodiments can be used to provide a temporary valve and filter during a procedure to repair a diseased or damaged valve or replace a diseased and/or damaged valve with a permanent valve. For example, the placement of the valve and filter apparatus within a body lumen (e.g., within the aorta, adjacent the aortic valve), can help to provide for a temporary valve and filter to regulate fluid flow and filter particulate matter from fluid flowing through the aorta during transluminal cardiac valve repair and/or replacement.
-
FIGS. 1A and 1B illustrate one embodiment of afilter system 100 shown in perspective view.Filter system 100 includes anelongate filter body 102 including anexpandable filter region 150 and avalve 104.FIGS. 1A and 1B provide a perspective illustration of thevalve 104 offilter system 100 in an open configuration (FIG. 1A ) and a closed configuration (FIG. 1B ). In addition, the perspectives illustrated inFIGS. 1A and 1B show thefilter system 100 in an expanded configuration, as will be discussed herein. - In the present embodiments, the
elongate filter body 102 defines alumen 106 extending from aproximal end 108 towards adistal end 110. In one embodiment, thelumen 106 can be concentric with an elongate axis of theelongate filter body 102. Thevalve 104 also defines alumen 112. In one example, thevalve 104 can be adjoined proximal thedistal end 110 of the elongate filter body, where thelumen 112 of thevalve 104 and thelumen 106 of theelongate filter body 102 can form asingle lumen 114. In other words, thelumens single lumen 114. Other configurations are also possible. - In the various embodiments,
filter system 100 allows for both unidirectional flow of fluid and filtering of the fluid passing through thelumens lumens valve 104 includes a reversiblysealable opening 116. In one embodiment, the reversiblysealable opening 116 can be formed by one ormore valve leaflets 118. In forming the reversiblysealable opening 116, thevalve leaflets 118 are configured to move between an open configuration (e.g.,FIG. 1A , allowing fluid to flow in afirst direction 193 through thelumens 106 and 112) and a closed configuration (e.g.,FIG. 1B , preventing fluid from flowing in asecond direction 197 opposite the first direction 193). - The
valve 104 can include any number of configurations so as to define thelumen 112 and provide the reversiblysealable opening 116 for unidirectional flow of the fluid through thelumen 112. For example, thevalve 104 can include aframe 120 that supports acover 122. In the various embodiments, thecover 122 defines the reversiblysealable valve leaflets 118 that provide for the unidirectional flow of a fluid through thelumen 112 of thevalve 104. - Examples of a valve suitable for use as
valve 104 is illustrated in U.S. patent application Ser. No. 10/741,995, entitled “Venous Valve Apparatus, System, and Method”, and in U.S. patent application Ser. No. 11/052,655, entitled “Venous Valve Apparatus, System, and Method”, both of which are hereby incorporated by reference in their entirety. As illustrated,frame 120 includes a variety of structural configurations. Generally, theframe 120 has a curved structural configuration, as will be discussed herein. For example, theframe 120 can include a firstelliptical member 124 and a secondelliptical member 126, as illustrated inFIGS. 1A and 1B . - In the various embodiments, the first
elliptical member 124 and the secondelliptical member 126 meet at afirst region 128 and asecond region 130, where thefirst region 128 and thesecond region 130 are opposite each other acrossaxis 132. Thefirst region 128 and thesecond region 130 can be located at any number of locations along the firstelliptical member 124 and the secondelliptical member 126. For example, thefirst region 128 and thesecond region 130 can be at or near a minor axis of the firstelliptical member 124 and the secondelliptical member 126. In an additional embodiment, thefirst region 128 and thesecond region 130 can be positioned away from the minor axis of the firstelliptical member 124 and the secondelliptical member 126. - While the term elliptical member is used herein, other shapes are possible for the structural members that help to form a valve according to the embodiments herein. For example, the
frame 120 can include circular members that meet at thefirst region 128 and thesecond region 130. Other shapes besides elliptical and circular are also possible. - The first
elliptical member 124 and the secondelliptical member 126 meet at thefirst region 128 and thesecond region 130 at anangle 134. In one embodiment, the size ofangle 134 when thevalve 104 is expanded can be selected based upon the type of body lumen and the body lumen size in which thevalve 104 is to be placed. Additional factors include, but are not limited to, alongitudinal length 136 and awidth 138 of thevalve 104. These factors, along with others discussed herein, can be used to provide theangle 134 that is sufficient to ensure that the firstelliptical member 124 and the secondelliptical member 126 have an appropriate expansion force against an inner wall of the body lumen in which thevalve 104 is being placed. - The
valve 104 also includes a flexible joint at and/or aroundaxis 132 that allows thevalve 104 to accommodate changes in body lumen size (e.g., diameter of the body lumen) by increasing or decreasingangle 134 when thevalve 104 is expanded. In addition, theframe 120 also has the ability to flex, as discussed herein, to allow for the distance between thefirst region 128 and thesecond region 130 to increase or decrease, thereby further accommodating changes in the body lumen size (e.g., diameter of the body lumen). Theframe 120 also provides sufficient contact and expansion force with the surface of a body lumen wall to encourage seating of thevalve 104 and to prevent retrograde flow, i.e.,second direction 197, within the body lumen. - The
frame 120 can be formed from a biocompatible metal, metal alloy, polymeric material, or combinations thereof, which allow theframe 120 to move radially between the collapsed and expanded state, as discussed herein. To accomplish this, the biocompatible metal, metal alloy, or polymeric material should exhibit a low elastic modulus and a high yield stress for large elastic strains that can recover from elastic deformations. Examples of suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof. In an additional embodiment, theframe 120 may be formed from a shape-memory material. Examples of a suitable shape-memory material include, but are not limited to, alloys of nickel and titanium in specific proportions known in the art as nitinol. Other materials are also possible. - The
valve 104 can further include one or more radiopaque markers 152 (e.g., tabs, sleeves, welds). For example, one or more portions of theframe 120 can be formed from a radiopaque material. Radiopaque markers can be attached to and/or coated onto one or more locations along theframe 120. Examples of radiopaque materials include, but are not limited to, gold, tantalum, and platinum. The position of the one or more radiopaque markers can be selected so as to provide information on the position, location and orientation of thevalve 104 during its implantation. - The
valve 104 further includes thecover 122. In the various embodiments, thecover 122 forms thevalve leaflets 118 joined tovalve frame 120. Thevalve leaflets 118 can deflect between a closed configuration (FIG. 1B ) in which retrograde fluid flow through thevalve 104 is restricted, and an open configuration (FIG. 1A ) in which antegrade fluid flow through thevalve 104 is permitted. In one embodiment,valve leaflets 118 of the valve are configured to open and close in response to the fluid motion and/or pressure differential across thevalve leaflets 118. - The example of
valve 104 shown inFIGS. 1A and 1B provide embodiments in which the surfaces defining the reversiblysealable opening 116 include afirst leaflet 140 and asecond leaflet 142 coupled to thevalve frame 120 to provide a two-leaflet configuration (i.e., a bicuspid valve) forvalve 104. Although the embodiments illustrated inFIGS. 1A-1B of the present invention show and describe a two-leaflet configuration forvalve 104, designs employing a different number of valve leaflets (e.g., tricuspid valve) are possible and considered within the scope of the embodiments. - The
valve leaflets 118 can have a variety of sizes and shapes. For example, each of the valve leaflets 118 (e.g.,first leaflet 140 and second leaflet 142) can have a similar size and shape. In an additional example, each of thevalve leaflets 118 need not havevalve leaflets 118 that are of a similar size and shape (i.e., the valve leaflets can have a different size and shape). -
Valve frame 120 can include an open frame construction (i.e.,valve frame 120 defines an opening) through whichvalve leaflets 118 can radially-collapse and radially-expand. Thevalve leaflets 118 can be provided over the open frame construction of thevalve frame 120 to direct fluid flow through reversiblysealable opening 116 under specific fluid flow conditions. In one embodiment, the material of thevalve leaflets 118 coupled to thevalve frame 120 can be sufficiently thin and pliable so as to permit radially-collapsing of thevalve leaflets 118 for delivery by catheter to a location within a body lumen. - In one embodiment, each of the
valve leaflets 118 includes sufficient excess material spanningvalve frame 120 such that fluid pressure (e.g., antegrade flow) acting on thevalve leaflets 118 forces thevalve 104 into an open configuration (FIG. 1A ).Valve leaflets 118 can further includearcuate edges FIG. 1A , that are positioned adjacent each other along a substantially catenary curve between thefirst region 128 and thesecond region 130 in the closed configuration (FIG. 1B ) ofvalve 104. Similarly,arcuate edges lumen 112 when thevalve 104 is in the open configuration (FIG. 1A ). - In an additional embodiment, in the open configuration the sufficient excess material spanning the
valve frame 120 can allow thevalve leaflets 118 to take on a semi-tubular structure, as shown inFIG. 1A , when fluid pressure opens thevalve 104. In an additional embodiment,arcuate edge valve 100 can open to approximately the full inner diameter of body lumen. - Each of the
valve leaflets 118 can further include a curve imparted thereto so as to provide aconcave structure 148 to theleaflet 118. Theconcave structure 148 allows thevalve leaflets 118 to better collect retrograde fluid flow to urgevalve leaflets 118 towards the closed configuration. For example, as retrograde flow begins, thevalve leaflets 118 respond by moving towards the center ofvalve 104. As thevalve leaflets 118 approach the center of the device thevalve leaflets 118 make sufficient contact to effectively close the reversiblysealable opening 116 ofvalve 104 and thereby restrict retrograde fluid flow. - In an additional embodiment, the
valve leaflets 118 can include one or more support structures. For example, thevalve leaflets 118 can include one or more support ribs having a predetermined shape. In one embodiment, the predetermined shape of the support ribs can include a curved bias so as to provide thevalve leaflets 118 with a curved configuration. Support ribs can be constructed of a flexible material and have dimensions (e.g., thickness, width and length) and cross-sectional shape that allows the support ribs to be flexible whenvalve leaflets 118 are urged into an open position, and stiff when thevalve leaflets 118 are urged into a closed position upon experiencing sufficient back flow pressure from the direction downstream from the valve. In an additional embodiment, support ribs can also be attached tovalve frame 120 so as to impart a spring bias to the valve leaflets in either the open or the closed configuration. - The
valve leaflets 118 can be constructed of a fluid-impermeable biocompatible material that can be either synthetic or biologic. Possible synthetic materials include, but are not limited to, expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, polyethlylene (PE), polyethylene terephthalate (PET), silk, urethane, Rayon, Silicone, or the like. Possible biologic materials include, but are not limited to allogeneic or xenograft material. These include explanted veins and decellularized basement membrane materials, such as small intestine submucosa (SIS) or umbilical vein. -
Valve leaflets 118 can be coupled to the various embodiments ofvalve frame 120, as described herein, in any number of ways. For example, a variety of fasteners can be used to couple the material of thevalve leaflets 118 to thevalve frame 120. Fasteners can include, but are not limited to, biocompatible staples, glues, and sutures. In one embodiment, the material of thevalve leaflets 118 can be wrapped at least partially around thevalve frame 120 and coupled using the fastener. In an additional embodiment,valve leaflets 118 can be coupled to the various embodiments ofvalve frame 120 through the use of heat sealing, solvent bonding, adhesive bonding, or welding thevalve leaflets 118 to either a portion of the valve leaflet 118 (i.e., itself) and/or thevalve frame 120.Valve leaflets 118 can also be attached tovalve frame 120 according to the methods described in U.S. Patent Application Publication 2002/0178570 to Sogard et al., which is hereby incorporated by reference in its entirety. - In an alternative embodiment, the
valve 104 can include three leaflets, with the various frames and covering configurations as described herein. Further,valve 104 can be configured to extend proximally and distally in a curvilinear manner to accommodate the coronary ostia and the diseased valve. For example, leaflets can extend past the coronary ostia in the central portion of the leaflets, and extend to accommodate the attachment points of the diseased valve by incorporating a tri-lobar saddle shaped configuration. In one embodiment, thevalve 104 can include a configuration that allows thevalve 104 to be place functionally distal to the coronary ostia for proper coronary perfusion, while maintaining sufficient clearance for the diseased valve and the repair or replacement of the diseased valve to be performed. Examples of a three leaflet valve suitable for use asvalve 104 are illustrated in U.S. patent application Ser. No. 11/107,162, entitled “Valve Apparatus, System and Method”, and U.S. patent application Ser. No. 10/933,088, entitled “Cardiac Valve, System, and Method”, which is hereby incorporated by reference in its entirety. - In various embodiments, a portion of the
elongate filter body 102 can include anexpandable filter region 150 to filter the unidirectional flow of the fluid moving through thevalve 104. As used herein, filtering of fluid can be accomplished through use of theexpandable filter region 150 by trapping and/or inhibiting the passage of particular matter released into and/or present in the fluid moving through thevalve 104. Trapped particulate matter can then be removed with thefilter system 100 through thelumen 106. - As illustrated in
FIGS. 1A-1B , thevalve 104 can be adjoined proximal thedistal end 110 of theelongate filter body 102. For example, theframe 120 of thevalve 104 can be coupled to theexpandable filter region 150 proximal thedistal end 110 of theelongate filter body 102. Methods of coupling theframe 120 to theexpandable filter region 150 of theelongate filter body 102 can be as described herein for coupling thevalve leaflets 118 to theframe 120. - As will be illustrated herein, the
expandable filter region 150 can move between a first configuration (e.g., a compressed state, shown inFIG. 3A ) and a second configuration (e.g., an expanded state, shown inFIGS. 1A-1B andFIGS. 2A-2B ). In one embodiment, theexpandable filter region 150 can expand from the first configuration to the second configuration due to force imparted by theframe 120 as it expands. In addition, theexpandable filter region 150 can expand from the first configuration to the second configuration by a combination of force imparted by theframe 120 as it expands and under pressure of the unidirectional flow of the fluid. Additionally, the force imparted by the frame when the valve is in the open configuration can help to maintain the expandable filter region expanded when under retrograde fluid flow, such as when the valve is in a closed configuration. In an additional embodiment, theexpandable filter region 150 can be configured to radially self-expand when released from a compressed state. - In the various embodiments, the
expandable filter region 150 in its deployed state can fill the cross-section area of the lumen in which theexpandable filter region 150 andvalve 104 are deployed. In addition,filter region 150 in its deployed state can apply sufficient pressure to the inner wall of the lumen to reduce the volume of fluid (e.g., blood) that may pass between thefilter region 150 and the surface of the lumen wall. In one embodiment, thevalve frame 120 can be used at least in part to apply the sufficient pressure to the inner wall of the body lumen. As will be appreciated, the area and shape defined by the expandable filter region 150 (e.g., the diameter of the expandable filter region) in its deployed state can be dependent upon the location in which the apparatus is intended to be used. - Examples of
expandable filter region 150 include those having a woven, braided and/or a knit configuration as the same will be known and understood by one of ordinary skill in the art. Alternatively, theexpandable filter regions 150 can be formed of a material having pores formed therein or imparted thereto. In the various embodiments, theexpandable filter regions 150 can be formed of a number of materials. Materials can include polymers, such as ePTFE, PTFE, polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, PE, PET, silk, urethane, Rayon, Silicone, polyamid, mixtures, and block co-polymers thereof. - In one embodiment,
expandable filter region 150 can be configured to reduce passage of potentially injurious emboli to arteries feeding the brain, heart, kidneys, and other tissues and organs. For example,expandable filter region 150 can help to reduce or prevent passage of emboli greater than about 5 to 1000 micrometers in cross-sectional size.Expandable filter region 150 may also prevent passage of emboli larger than 50 to 200 micrometers in cross-sectional size. Multiple regions or layers ofexpandable filter region 150 may be incorporated to more efficiently filter emboli, such as a 200 micrometer portion of theexpandable filter region 150 to capture larger particles and a 75 micrometer portion of theexpandable filter region 150 to capture smaller particles. - Additional examples of the
expandable filter region 150 include the radially self-expanding configurations formed from temperature-sensitive memory alloy which changes shape at a designated temperature or temperature range. Examples of such materials include, but are not limited to, nitinol and nitinol-type metal alloys. Alternatively, self-expanding configurations for theexpandable filter region 150 include those having a spring-bias imparted into the members forming thefilter region 150. Theexpandable filter region 150 can have a woven, braided and/or a knit configuration that can also impart a self-expanding aspect to theexpandable filter region 150. - In an additional embodiment, the
filter region 150 can further includeradiopaque markers 152. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location of thevalve 104 and/or theexpandable filter region 150. Other portions offilter system 100 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of thefilter system 100. - The
elongate filter body 102 can further include a fluidtight plug 154 positioned within thelumen 106 of theelongate filter body 102. In one embodiment, the fluidtight plug 154 can be positioned proximal theexpandable filter region 150 so as to occlude thelumen 106, thereby directing the unidirectional flow of the fluid from thelumen 106 through theexpandable filter region 150. - The fluid
tight plug 154 can have a variety of shapes and configurations. For example, afirst end 155 and asecond end 157 of the fluidtight plug 154 can include a flat planar surface. In an alternative embodiment, thefirst end 155 of the fluid tight plug can include a conical configuration, as shown inFIGS. 1A and 1B . Other shapes and configurations for the fluidtight plug 154 are also possible. -
FIGS. 2A and 2B illustrate an additional embodiment of afilter system 200.FIGS. 2A and 2B provide a perspective illustration of thefilter system 200 that includes both theelongate filter body 202, as described herein, and thevalve 204. In the present example, however, thevalve 204 includes aframe 220 and acover 222, includingvalve leaflets 240 and 242 (shown inFIG. 2A ), having a different configuration as compared to thevalve 104 described above inFIGS. 1A and 1B . One example ofvalve 204 is illustrated in U.S. patent application Ser. No. 10/741,992, entitled “Venous Valve Apparatus, System, and Method”, which is hereby incorporated by reference in its entirety. - The
frame 220 ofvalve 204 includes anouter surface 256 and aninner surface 258 opposite theouter surface 256. Theinner surface 258 defines thelumen 212 of thevalve 204 for passing fluid therethrough. Theframe 220 also includes afirst end 262 and asecond end 260. In one embodiment, thecover 222 can be located over at least theouter surface 256 of theframe 220. For example, thecover 222 can extend around a perimeter of theframe 220 so as to completely cover theouter surface 256 of theframe 220. In other words, thecover 222 extends over the outer surface of theframe 220 so that there are no exposed portions of theouter surface 256 of theframe 220. In an additional embodiment, thecover 222 can also be located over at least theinner surface 258 of theframe 220. A further embodiment includes thecover 222 located over at least theouter surface 256 and theinner surface 258. - In one embodiment, the
frame 220 can include an open frame configuration that includes afirst vertex 263 and asecond vertex 264 relative thesecond end 260 of theframe 220.Frame 220 can further include afirst valley 266 and asecond valley 268 adjacent thesecond end 260 relative thefirst vertex 263 and thesecond vertex 264. As illustrated inFIGS. 2A and 2B , thefirst vertex 263 and thesecond vertex 264 can be positioned opposite each other along a common axis 270 (shown inFIG. 2B ).FIGS. 2A and 2B also illustrate that thefirst valley 266 and thesecond valley 268 can be positioned opposite each other and perpendicular toaxis 270. Other relative positions for the first andsecond vertex second valley - The
cover 222 can further includevalve leaflets sealable opening 216 for the unidirectional flow of the fluid through thelumen 212. For example, the surfaces of thecover 222 can be deflectable between a closed configuration (FIG. 2B ) in which fluid flow through thelumen 212 can be restricted and an open configuration (FIG. 2A ) in which fluid flow through thelumen 212 can be permitted in response to the fluid motion and/or pressure differential across thevalve leaflets - The example of
valve 204 shown inFIGS. 2A and 2B provide embodiments in which the surfaces defining the reversiblysealable opening 216 include thefirst leaflet 240 and thesecond leaflet 242 coupled to thevalve frame 220 to provide a two-leaflet configuration (i.e., a bicuspid valve) forvalve 204. Although the embodiments illustrated inFIGS. 2A and 2B of the present invention show and describe a two-leaflet configuration forvalve 204, designs employing a different number of valve leaflets (e.g., tricuspid valve) are also possible. - In one embodiment, each of the
valve leaflets valve frame 220 such that fluid pressure (e.g., antegrade flow) acting on thevalve leaflets valve 204 into an open configuration (FIG. 2A ).Valve leaflets FIGS. 1A and 1B and shown as 144 and 146, that are positioned adjacent each other along a substantially catenary curve between thefirst vertex 263 and thesecond vertex 264 in the closed configuration (Figure B) ofvalve 204. Similarly,arcuate edges lumen 212 when thevalve 204 is in the open configuration (FIG. 2A ). - In an additional embodiment, in the open configuration the sufficient excess material spanning the
valve frame 220 between thefirst vertex 263 and thesecond vertex 264 can allow thevalve leaflets FIG. 2A , when fluid pressure opens thevalve 204. In an additional embodiment,arcuate edge valve 204 can open to approximately the full inner diameter of body lumen. - Each of the
valve leaflets leaflet valve leaflets valve leaflets FIG. 2B ). For example, as retrograde flow begins, thevalve leaflets valve 204. As thevalve leaflets valve leaflets sealable opening 116 ofvalve 104 and thereby restrict retrograde fluid flow, i.e.,second direction 197 as shown inFIGS. 1A and 1B . -
FIGS. 3A and 3B provide a further illustration of the filter system 300 (i.e., theelongate filter body 302,valve 304, and filter region 350) that includes asheath 374 having alumen 376.FIGS. 3A and 3B provide a sectional illustration of thefilter system 300 at least partially contained within alumen 376 of the sheath 374 (FIG. 3A ) and of thefilter system 300 at least partially deployed from thelumen 376 of the sheath 374 (FIG. 3B ). - In various embodiments, both the
valve 304 and thefilter region 350 of theelongate filter body 302 can be releasably positioned in a coaxial arrangement within thelumen 376 of thesheath 374. As discussed herein, the configuration of thesupport frame 320 provides thevalve 304 with sufficient flexibility to move between the first configuration 342 (e.g., a retracted state within thelumen 376 of thesheath 374 as shown inFIG. 3A ) and the second configuration 344 (e.g., an extended state outside thelumen 376 of thesheath 374 as shown inFIG. 3B ). - In one embodiment, the
valve 304 can be configured to reside in the compressed state when retracted within thelumen 376 of thesheath 374, as illustrated inFIG. 3A , and in an expanded state when extended from thelumen 376 of thesheath 374, as illustrated inFIG. 3B . In one embodiment, thevalve 304 expands from its compressed state within thelumen 376 to the deployed state when thesheath 374 is retracted from around thevalve 304. - The
sheath 374 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof. In addition, thesheath 374 can have a wall thickness and an inner diameter sufficient to maintain both thevalve 304 and theexpandable filter region 350 in the retracted state when they are positioned within thelumen 376. In an additional embodiment, thesheath 374 can further includeradiopaque markers 352. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location and allow for visualization of the location and position of parts of thesheath 374. - In the various embodiments, the
support frame 320 of thecardiac valve 304 expands to increase thediameter 312 of thelumen 306 of thevalve 304 as thevalve 304 is extended from thesheath 374. In one embodiment, thediameter 312 of thelumen 306 can be determined based upon the type of body lumen and the body lumen size in which thevalve 304 is to be placed. In an additional example, there can also be a minimum value for the width for thesupport frame 320 that ensures that thevalve 304 will have an appropriate expansion force against the inner wall of the body lumen to prevent retrograde flow within the body lumen. - In addition, the
lumen 306 of theelongate filter body 302 in thefilter region 350 also increases in diameter as thevalve 304 and theelongate filter body 302 are extended from thesheath 374. In one embodiment, theexpandable filter region 350 can expand from the first configuration to the second configuration due in part to force imparted by theframe 320 as it expands and under pressure of the unidirectional flow of the fluid. In an additional embodiment, theexpandable filter region 350 can be configured to radially self-expand, as the same has been described herein, when released from its compressed state within thelumen 376 of thesheath 374. - The
expandable filter region 350 in its deployed state can fill the cross-section area of a body lumen in which thevalve 304 andexpandable filter region 350 are deployed. In addition,filter region 350 in its deployed state can apply sufficient pressure to the inner wall of the body lumen to reduce the volume of fluid (e.g., blood) that may pass between thefilter region 350 and the surface of the body lumen wall. As will be appreciated, the area and shape defined by the expandable filter region 350 (e.g., the diameter of the expandable filter) in its deployed state will be dependent upon the location in which the filter system is intended to be used. - The
filter system 300 can be extended and retracted from thelumen 376 of thesheath 374 in any number of ways. For example, theelongate filter body 302 can be pulled longitudinally within thelumen 376 of thesheath 374 so as to retract thevalve 304 and thefilter region 350 of theelongate filter body 302. In this embodiment, theelongate filter body 302, supported by thesheath 374, provides sufficient column strength to allow force imparted at theproximal end 308 of theelongate filter body 302 to retract thevalve 304 and thefilter region 350. - In an additional embodiment, a portion of the
elongate filter body 302 extending from thefilter region 350 to theproximal end 308 can be reinforced and/or have an alternative construction relative thefilter region 350 so as to impart sufficient column strength to theelongate filter body 302. Theelongate filter body 302 can then be pushed longitudinally within thelumen 376 of thesheath 374 so as to extend thevalve 304 and thefilter region 350 of theelongate filter body 302. - In an additional embodiment, the
valve 304 and thefilter region 350 can be deployed and retracted by moving thesheath 374 relative theelongate filter body 302. In this embodiment, theelongate filter body 302 can be held while thesheath 374 is moved longitudinally so as to either deploy or retract thevalve 304 and thefilter region 350. - The
filter system 300 and thesheath 374 can further include handles positioned at theproximal end 308 of theelongate filter body 302 and afirst sheath end 378 of thesheath 374. In one embodiment, thesheath 374 includes ahandle 382 and theelongate filter body 302 includes ahandle 384.Handles sheath 374 and theelongate filter body 302 to move relative to each other so as to extend and/or retract the valve and a portion of the elongate filter body from thelumen 376 of thesheath 374. In one embodiment, the distance between thehandles valve 304 and thefilter region 350 to effectively deploy theexpandable filter region 350 andvalve 304. Other configurations and relational lengths are possible. - In an additional embodiment,
filter system 300 and thesheath 374 can further include asleeve 386 having aslit 388 and apull tab 390 positioned between the handles during delivery to prevent inadvertent exposure of thevalve 304 and filterregion 350. For example, thesleeve 386 can be stripped from thefilter system 300 by pulling the pull tab once thesheath 374 has been placed at the predetermined location at which thevalve 304 and thefilter region 350 are to be deployed. Other removable structures for preventing inadvertent exposure of thevalve 304 and filterregion 350 are also possible. - In an additional embodiment, the
filter system 300, as shown inFIG. 3C can be extended and/or retracted from thesheath 374 through the use of adeployment rod 394. In one embodiment, thedeployment rod 394 extends from theproximal end 308 of theelongate filter body 302 through thelumen 376 to the fluidtight plug 354, as the same has been described in connection withFIGS. 1A and 1B . In one embodiment, thedeployment rod 394 can be used to move theelongate filter body 302 and thevalve 304 relative thesheath 374. - For example, the
deployment rod 394 can extend through thelumen 312 to the fluidtight plug 354, where thedeployment rod 394 can be used to push thefilter system 300 relative thesheath 374 to deploy thevalve 304 and thefilter region 350 and/or pull thefilter system 300 relative thesheath 374 to draw thevalve 304 and thefilter region 350 back into its compressed state within thelumen 376 of thesheath 374. Alternatively, thedeployment rod 394 can be used to change the position of thevalve 304 and filterregion 350 once deployed from a first position within the lumen to a second position. - In the various embodiments, the
deployment rod 394 and the fluidtight plug 354 can further include releasably interconnecting members to allow thedeployment rod 394 and the fluidtight plug 354 to be separated. For example, the fluidtight plug 354 can include a socket having threads to receive and interact with a threaded portion of thedeployment rod 394. This structure allows for thedeployment rod 394 to be inserted through thelumen 376 of theelongate filter body 302 to the fluidtight plug 354, where the treaded portion of thedeployment rod 394 can be screwed into the threaded socket of the fluidtight plug 354. Thedeployment rod 394 can then be removed from thelumen 376 by unscrewing the threaded portion of thedeployment rod 394 from the threaded socket of the fluidtight plug 354. As will be appreciated, other ways of decoupling thedeployment rod 394 and the fluidtight plug 354 are also possible. - In one embodiment, the
deployment rod 394 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof. In addition, thedeployment rod 394 can be formed of medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof. -
FIGS. 4A-4D provides a further illustration of thefilter system 400 that includes thesheath 474, as previously discussed, and acatheter 401 and anapparatus 445.FIGS. 4A-4D provide perspective illustrations of thefilter system 400 at least partially contained within thelumen 476 of thesheath 474, with thecatheter 401 and theapparatus 445 at least partially contained within alumen 406 of theelongate filter body 402. - Examples of the
catheter 401 and theapparatus 445 are illustrated in U.S. patent application Ser. No. 11/049,000, entitled “Vascular Catheter, System, and Method”, which is hereby incorporated by reference in its entirety. In the various embodiments, thecatheter 401 includes anelongate body 403 having afirst lumen 405 extending between aproximal end 407 and adistal end 409. In one embodiment, thefirst lumen 405 allows for additional elongate members to travel along a longitudinal axis of theelongate body 402. - The
catheter 401 further includes afirst cutting head 411 having ablade 413 and an elongate pullingmember 415. Thefirst cutting head 411 can be positioned adjacent thedistal end 409 of theelongate body 403 of thecatheter 401 with the elongate pullingmember 415 extending through thefirst lumen 405. In one embodiment, the elongate pullingmember 415 can slide within thefirst lumen 405 to move thefirst cutting head 411 relative thedistal end 409 of theelongate body 403 of thecatheter 401. - The
catheter 401 also includes asecond cutting head 417 having ablade 419. Thesecond cutting head 417 can be positioned adjacent thedistal end 409 of theelongate body 403 between thedistal end 409 and thefirst cutting head 411. Theblade 413 of thefirst cutting head 411 can move relative theblade 419 of thesecond cutting head 417 to provide a shearing action. In one example, the shearing action can be sufficient for cutting cardiac tissue. -
FIG. 4A further illustrates an embodiment in which the second cutting head includes an elongate pushingmember 421. In one embodiment, the elongate pushingmember 421 can slide within thefirst lumen 405 to move thesecond cutting head 417 relative thedistal end 409 of theelongate body 403 and thefirst cutting head 411. In one embodiment, the elongate pullingmember 415 can be arranged concentrically with the elongate pushingmember 421 in thefirst lumen 405. - As illustrated, the elongate pulling
member 415, the elongate pushingmember 421 and thefirst lumen 405 of theelongate body 403 can be positioned coaxially. In one embodiment, thelumen 405 has a diameter sufficient to accommodate the elongate pushingmember 421. Similarly, the elongate pushingmember 421 had a diameter sufficient to accommodate the elongate pullingmember 415. - In addition, the elongate pulling
member 415 and the elongate pushingmember 421 can be structured such that their relative rotational movement is restricted. In other words, relative axial rotation of the elongate pullingmember 415 and the elongate pushingmember 421 is restricted due to the structure of themembers members members members members members - In addition to providing a sufficient diameter, a gap can exist between the opposing surfaces of the
first lumen 405 and the elongate pushingmember 421 to allow the elongate pushingmember 421 to move through thefirst lumen 405 from force applied at the proximal end of the elongate pushingmember 421. Similarly, a gap can exist between the opposing surfaces of the elongate pushingmember 421 and the elongate pullingmember 415 to allow the elongate pushingmember 421 and the elongate pullingmember 415 to move relative each other from force applied at the proximal end of the elongate pushingmember 421 and/or the elongate pullingmember 415. Theelongate pull member 415 can further include alumen 471 for tracking over a guidewire. A lubricant can be included on the surfaces of the elongate pullingmember 415, the elongate pushingmember 421 and thefirst lumen 405. - The
first cutting head 411 further includes a shape conducive to passing thecatheter 401 and thefilter system 400 through a body lumen (e.g., a lumen of the cardiovascular system). For example, thefirst cutting head 411 can include a conical shape having afirst end 423 and asecond end 425, where thefirst end 423 has a diameter that is less than a diameter of thesecond end 425. Other shapes are also possible. In addition, the shape of thefirst cutting head 411 can be configured to protectively house theblade 413 from structures passing by thefirst end 423 towards thesecond end 425. In other words, the shape of thefirst cutting head 411 can be used to shield theblade 413 from unintentionally interfering and/or cutting tissue within a body lumen. - In one embodiment, the
blade 413 can be radially positioned relative the elongate pullingmember 415 generally along thesecond end 425 of thefirst cutting head 411. As will be appreciated, thefirst cutting head 411 can include more than oneblade 413. Eachblade cutting edge blades first cutting head 411 can move relative thesecond cutting head 417 to allow thecutting edge 427 of theblade 413 of thefirst cutting head 411 to slide past thecutting edge 429 of theblade 417 of thesecond cutting head 417. Example of suitable materials for theblades - In one embodiment,
blades first cutting head 411 and thesecond cutting head 417, respectively, in any number of ways. For example,blades blades - In an additional embodiment, the
first cutting head 411 can be configured to receive and house at least a portion of thesecond cutting head 417, including theblade 419, such that thesecond blade 419 does not pass beyond thefirst cutting head 411. For example, the first cutting head can include a socket that extends radially relative the elongate pullingmember 415 and distally from theblade 413 to receive theblade 419 of thesecond cutting head 417 as theblade 419 passes theblade 413. In one embodiment, theblade 419 can be positioned within the socket of thefirst cutting head 411 as thecatheter 401 is moved through a lumen. -
Catheter 401 can have various lengths between theproximal end 407 and thefirst cutting head 411. In one embodiment, the length between theproximal end 407 and thefirst cutting head 411 is sufficient to allow thecatheter 401 to be percutaneously implanted through a patient's vasculature to position the cutting heads (e.g., the first and second cutting heads) at a predetermined location. Examples of the predetermined locations include, but are not limited to, cardiovascular locations such as on or adjacent to a cardiac valve of the heart (e.g., the aortic valve), including within a chamber of the patient's heart (e.g., the left ventricle of the heart). As will be appreciated, the length between theproximal end 407 and thefirst cutting head 411 will be dependent upon each patient's physiological structure and the predetermined location within the patient. - The
elongate body 403 of thecatheter 401, the elongate pullingmember 415, the elongate pushingmember 421, thesecond cutting head 417 and thefirst cutting head 411 can be formed from a wide variety of materials and in a wide variety of configurations. For example, the materials may include, but are not limited to, one or more of polyvinyl chloride (PVC), polyethylene (PE), polyolefin copolymer (POC), polyethylene terephthalate (PET), polyamid, mixtures, and block co-polymers thereof. Alternatively, the materials may include one or more alloys in any number of configurations. For example, the materials may include stainless steel (e.g., 316L), titanium, or other medical grade alloys as are known. These materials may also have a woven configuration or a solid extruded configuration. - The selection of material and configuration allows for the
elongate body 403, the elongate pullingmember 415, the elongate pushingmember 421, thesecond cutting head 417 and thefirst cutting head 411 to each have the flexibility, and the ability to be either pushed and/or pulled thereby accomplishing the actions described for the components herein. As will be appreciated, selection of the material can be based generally on a broad range of technical properties, including, but not limited to, modulus of elasticity, flexural modulus, and Shore A hardness required for the embodiments of the present invention. Components of the present apparatus and/or system can also be coated for lubrication, for abrasion resistance, or to deliver an anticoagulatory drug. - As an alternative configuration, the cutting mechanism of
first cutting head 411 andsecond cutting head 417 can be accomplished by alternate cutting, shearing, slicing, grinding or ablative means as are known for other purposes. For example, thermal energy can be used to weaken or slice the diseased valve, rolling cutters could be incorporated, or a “cutting balloon” mechanism could be incorporated. - In an additional embodiment, the
catheter 401 can further includeradiopaque markers 431. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location of thefirst cutting head 411 and thesecond cutting head 417. In addition, radiopaque markers can be used to mark the location ofblades catheter 401 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of thecatheter 401. - As illustrated in
FIG. 4A ,catheter 401 can reside at least partially within thelumen 406 of the elongate filter body.FIG. 4B provides an example in which both thevalve 404 and thefilter region 450 have been extended from thesheath 474, as discussed herein, with thecatheter 401 at least partially extending distally from thevalve 404. In the various embodiments, the valve leaflets ofvalve 404 can seat around theelongate body 403 of thecatheter 401 to provide the reversibly sealable opening of thevalve 404. - In the various embodiments, the
elongate body 403 can travel longitudinally within thelumen 406 of theelongate filter body 402 to extend and retract thedistal end 409 of thecatheter 401 relative thevalve 404 of thefilter system 400. Theelongate filter body 402 can further include a sealing ring that allows theelongate body 403 of thecatheter 401 to move longitudinally while maintaining a fluid tight seal within thelumen 406 of theelongate filter body 402. - In addition to the structures described herein, the
elongate body 403 ofcatheter 401 further includes asecond lumen 435, as shown inFIG. 4A . In one embodiment, thesecond lumen 435 can extend between theproximal end 407 and thedistal end 409 of theelongate body 403, where thesecond lumen 435 can be coupled in fluid tight communication to aninflatable balloon 437 on theelongate body 403. Thecatheter 401 can further include aninflation device 495 that can reversibly couple in fluid tight communication with thesecond lumen 435 to provide fluid pressure to inflate and deflateballoon 437. - In one embodiment, the
inflatable balloon 437 can be positioned adjacent thedistal end 409 of theelongate body 403 and proximal to thesecond cutting head 417. Theinflatable balloon 437 can be inflated from a deflated state to an inflated state by pressure applied by fluid moving through thesecond lumen 435. In addition, thecatheter 401 further includes anexpandable stent 439 positioned over at least a portion of theinflatable balloon 437. Theexpandable stent 439 can move between a compressed state, as shown inFIG. 4B , and an expanded state, as shown inFIG. 4C , using theinflatable balloon 437. In one embodiment, theexpandable stent 439 can be deployed over cardiac tissue sheared using the first and second cutting heads 411 and 417 using theinflatable balloon 437. -
Catheter 401 can further include anannular push ring 441 positioned between thesecond cutting head 417 and theinflatable balloon 437. Theannular push ring 441 can be used for contacting and moving at least a portion of cardiac tissue sheared with the first and second cutting heads 411 and 417. For example, the first and second cutting heads 411 and 417 can be used to shear cardiac tissue (e.g., one or more cusps of a valve). Theannular push ring 441 can then be advanced into contact with the sheared cardiac tissue. As theannular push ring 441 advances the sheared cardiac tissue can be directed towards the wall of the lumen.Stent 439 can then be positioned over at least a portion of the sheared cardiac tissue positioned using theannular push ring 441.Stent 439 can then be deployed using theinflatable balloon 437 to position at least a portion of the sheared cardiac tissue between the expandedstent 439 and the wall of the lumen. As will be appreciated, the dimensions and physical characteristics of thestent 439 will be dependent upon the location in which thestent 439 is to be implanted. - The
apparatus 445 can further include acardiac valve 455. Thecardiac valve 455 can be releasably positioned adjacent theexpandable stent 439 over at least a portion of theinflatable balloon 437. Generally,cardiac valve 455 can be implanted within the fluid passageway of a body lumen, such as for replacement of a valve structure within the body lumen to regulate the flow of a bodily fluid through the body lumen in a single direction. - With respect to the
apparatus 445, thecardiac valve 455 can be configured to reside in a compressed state over at least a portion of theinflatable balloon 437. Using the inflatable balloon, thecardiac valve 455 can be expanded into a deployed state as illustrated inFIGS. 4C and 4D . - One example of
cardiac valve 455 includesvalve 204 as described herein. An additional embodiment ofcardiac valve 455 is illustrated in U.S. patent application Ser. No. 11/049,000, entitled “Vascular Catheter, System, and Method, which is hereby incorporated by reference in its entirety. - Generally, the
cardiac valve 455 includes a support frame and a cover. The cover of thecardiac valve 455 can be positioned over at least the outer surface of the support frame. In one embodiment, the cover includes surfaces defining a reversibly sealable opening for unidirectional flow of a liquid through the lumen of thecardiac valve 455. - The
filter system 400,catheter 401 and theapparatus 445 can further include handles to allow the various components to be moved relative each other. For example, handles 479 can allow the elongate pushingmember 421 and/or the elongate pullingmember 415 to be moved relative each other. Handle 481 can allow thecatheter 401 to be moved relative theapparatus 445 and thesheath 474. In addition, handles 483 can allow thesheath 474 and thefilter system 400 to be moved relative each other. As will be appreciated, other structures may be used in place of or in addition to the handles to allow the various components of thefilter system 400,catheter 401, andapparatus 445 to move relative each other. - The embodiments of the present invention further include methods for forming the filter system and apparatus, as discussed herein. For example, embodiments of the present invention can be formed by providing an elongate filter body that includes the expandable filter region defining a lumen. The valve can further be provided, where the valve can be adjoined proximal the distal end of the elongate filter body to form a single lumen through which fluid flows unidirectionally through the valve and the elongate filter body to filter the fluid. As provided herein, the valve can define a reversibly sealable opening for the unidirectional flow of fluid through the lumen of the valve.
- In one embodiment, the expandable filter region can be configured to move between a first configuration and a second configuration. In one embodiment, the movement from the first configuration to the second configuration can occur as the valve expands in addition to under pressure of the unidirectional flow of the fluid. The elongate filter body can also be provided with the fluid tight plug to direct the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid. In these embodiments, the fluid tight plug can include various shapes and sizes and can be positioned according to the embodiments described herein.
- In various embodiments, the valve can be provided with a support frame having various configurations. A first configuration can include a compressed configuration and a second configuration can include an expanded configuration. In various embodiments, expansion of the support frame can be supplemented by fluid flowing into the lumen of the elongate filter body.
- The filter system and apparatus, as discussed herein, can further include providing the catheter having the first cutting head and the second cutting head, as discussed herein. The first cutting head can include the blade and the elongate pulling member, where the first cutting head can be positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen of the catheter. The elongate pulling member can then slides within the first lumen to move the first cutting head relative the distal end of the elongate body. The second cutting head can also include a blade, and be positioned adjacent the distal end of the elongate body between the distal end and the first cutting head. The blade of the first cutting head can be moved relative the blade of the second cutting head to provide the shearing action for cardiac tissue. The catheter extends though the lumen of the elongate filter body and the lumen of the valve.
- In additional embodiments, the filter system and apparatus further include providing a second lumen to the elongate body, where the second lumen can be in fluid tight communication with the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head. The expandable stent can then be positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue. In further embodiment, the annular push ring can also be provided between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue. The embodiments can also include providing the cardiac valve positioned over the inflatable balloon, where the cardiac valve can be deployed through the use of the inflatable balloon.
- While the present invention has been shown and described in detail above, it will be clear to the person skilled in the art that changes and modifications may be made without departing from the spirit and scope of the invention. As such, that which is set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. The actual scope of the invention is intended to be defined by the following claims, along with the full range of equivalents to which such claims are entitled.
- In addition, one of ordinary skill in the art will appreciate upon reading and understanding this disclosure that other variations for the invention described herein can be included within the scope of the present invention. For example, the
support frame 120 and/or thecover 122 can be coated with a non-thrombogenic biocompatible material, as are known or will be known. - In the foregoing Detailed Description, various features are grouped together in several embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the embodiments of the invention require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.
Claims (14)
1. A filter and valve system for use in a body lumen, comprising:
an elongate filter body having a tubular shaft including an expandable filter region fixedly attached at a distal end of the tubular shaft which together define a lumen extending from a proximal end of the tubular shaft toward a distal end of the expandable filter region, the expandable filter region having a collapsed delivery configuration and an expanded configuration; and
a balloon catheter comprising a catheter shaft including a first lumen and a second inflation lumen coupled in fluid tight communication to a distal inflatable balloon on the catheter shaft,
wherein the distal inflatable balloon has a first collapsed balloon configuration and a second expanded balloon configuration;
a balloon expandable stent mounted on the distal inflatable balloon when the distal inflatable balloon is in the first collapsed balloon configuration; and
a cardiac valve releasably positioned adjacent the balloon expandable stent over at least a portion of the distal inflatable balloon when the distal inflatable balloon is in the first collapsed balloon configuration,
wherein the balloon catheter, balloon expandable stent, and cardiac valve are sized and adapted to pass through the lumen of the tubular shaft and the expandable filter region when the expandable filter region is in the expanded configuration and the distal inflatable balloon is in the first collapsed balloon configuration.
2. The filter and valve system of claim 1 , wherein the balloon catheter, balloon expandable stent, and cardiac valve are sized and adapted to pass through the lumen of the tubular shaft and the expandable filter region when the expandable filter region is in the collapsed delivery configuration and the distal inflatable balloon is in the first collapsed balloon configuration.
3. The filter and valve system of claim 1 , further comprising a sheath defining a lumen wherein the expandable filter region is at least partially contained within the lumen defined by the sheath when the expandable filter region is in the collapsed delivery configuration.
4. The filter and valve system of claim 3 , wherein the expandable filter region is self-expanding and self-expands upon withdrawal of the sheath relative to the expandable filter region.
5. The filter and valve system of claim 3 , wherein the expandable filter region is formed from temperature sensitive memory alloy which changes shape at a designated temperature.
6. The filter and valve system of claim 5 , wherein the temperature sensitive memory alloy which changes shape at a designated temperature is nitinol or a nitinol-type alloy.
7. The filter and valve system of claim 1 , wherein the expandable filter region is formed as a woven, braided, or a knit body.
8. The filter and valve system of claim 1 , wherein the cardiac valve includes a support frame and a cover.
9. The filter and valve system of claim 8 , wherein the cover is positioned over t least a portion of an outer surface of the support frame.
10. The filter and valve system of claim 8 , wherein the cover includes surfaces defining a reversibly sealable opening for unidirectional flow of a liquid through the lumen of the cardiac valve.
11. The filter and valve system of claim 1 , wherein cardiac valve is expanded into a deployed state by inflation of the distal inflatable balloon from the first collapsed balloon configuration to the second expanded balloon configuration.
12. The filter and valve system of claim 1 , wherein the elongate filter body further includes a fluid tight plug positioned within the lumen defined thereby at the distal end of the tubular shaft.
13. The filter and valve system of claim 1 , wherein the elongate filter body further includes a valve defining a valve lumen having a reversibly sealable opening for unidirectional flow of a fluid through the valve lumen.
14. The filter and valve system of claim 1 , wherein the valve is fixedly attached to the expandable filter region of the elongate filter body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/257,498 US20160374793A1 (en) | 2005-02-01 | 2016-09-06 | Filter system and method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/049,019 US20060173490A1 (en) | 2005-02-01 | 2005-02-01 | Filter system and method |
US14/604,125 US9622859B2 (en) | 2005-02-01 | 2015-01-23 | Filter system and method |
US15/257,498 US20160374793A1 (en) | 2005-02-01 | 2016-09-06 | Filter system and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/604,125 Continuation US9622859B2 (en) | 2005-02-01 | 2015-01-23 | Filter system and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160374793A1 true US20160374793A1 (en) | 2016-12-29 |
Family
ID=36168792
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/049,019 Abandoned US20060173490A1 (en) | 2005-02-01 | 2005-02-01 | Filter system and method |
US14/604,125 Expired - Fee Related US9622859B2 (en) | 2005-02-01 | 2015-01-23 | Filter system and method |
US15/257,498 Abandoned US20160374793A1 (en) | 2005-02-01 | 2016-09-06 | Filter system and method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/049,019 Abandoned US20060173490A1 (en) | 2005-02-01 | 2005-02-01 | Filter system and method |
US14/604,125 Expired - Fee Related US9622859B2 (en) | 2005-02-01 | 2015-01-23 | Filter system and method |
Country Status (5)
Country | Link |
---|---|
US (3) | US20060173490A1 (en) |
EP (3) | EP2537486B1 (en) |
JP (1) | JP4991572B2 (en) |
CA (1) | CA2596296A1 (en) |
WO (1) | WO2006083472A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9987133B2 (en) | 2008-02-26 | 2018-06-05 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US7854755B2 (en) * | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
JP5523700B2 (en) | 2005-04-04 | 2014-06-18 | フレキシブル ステンティング ソリューションズ,インク. | Flexible stent |
US7935075B2 (en) * | 2005-04-26 | 2011-05-03 | Cardiac Pacemakers, Inc. | Self-deploying vascular occlusion device |
DE102006024176B4 (en) * | 2006-05-23 | 2008-08-28 | Pah, Gunnar M. | A device for filtering blood in the removal of heart valve stenosis and methods for eliminating heart valve stenosis |
JP5604110B2 (en) * | 2007-02-05 | 2014-10-08 | ボストン サイエンティフィック リミテッド | System for delivering a valve |
US7988723B2 (en) | 2007-08-02 | 2011-08-02 | Flexible Stenting Solutions, Inc. | Flexible stent |
DE102007056946A1 (en) * | 2007-11-27 | 2009-05-28 | Gunnar Pah | Device for filtering blood |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
CA2722296A1 (en) | 2008-04-29 | 2009-11-05 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US9149376B2 (en) | 2008-10-06 | 2015-10-06 | Cordis Corporation | Reconstrainable stent delivery system |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
WO2010138919A2 (en) | 2009-05-28 | 2010-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
JP5665149B2 (en) * | 2009-08-28 | 2015-02-04 | メドトロニック 3エフ セラピュティックス インコーポレイテッド | Transapical transport device and method of use |
US8696698B2 (en) * | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US9539081B2 (en) * | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US8500775B2 (en) * | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
US8425455B2 (en) | 2010-03-30 | 2013-04-23 | Angiodynamics, Inc. | Bronchial catheter and method of use |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9700368B2 (en) | 2010-10-13 | 2017-07-11 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
US20130096606A1 (en) * | 2011-10-17 | 2013-04-18 | William C. Bruchman | Embolic protection devices and related systems and methods |
EP2768550A4 (en) * | 2011-10-19 | 2015-06-24 | Michael Anthony T Don | Apparatus and procedure for trapping embolic debris |
US9492265B2 (en) | 2012-01-06 | 2016-11-15 | Emboline, Inc. | Integrated embolic protection devices |
US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
EP2844163A4 (en) * | 2012-04-30 | 2015-09-23 | Bio2 Medical Inc | Multi-lumen central access vena cava filter apparatus for clot management and method of using same |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US20140257362A1 (en) * | 2013-03-07 | 2014-09-11 | St. Jude Medical, Cardiology Division, Inc. | Filtering and removing particulates from bloodstream |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
CA2910763C (en) * | 2013-04-12 | 2021-05-25 | T. Anthony Don Michael | Apparatus and procedure for trapping embolic debris |
US20150119977A1 (en) * | 2013-10-30 | 2015-04-30 | The Regents Of The University Of Michigan | System and method to limit cerebral ischemia |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
CN112807074A (en) | 2014-05-12 | 2021-05-18 | 弗吉尼亚暨州立大学知识产权公司 | Electroporation system |
WO2016100325A1 (en) | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
EP3078350B1 (en) * | 2015-04-09 | 2018-01-31 | Frid Mind Technologies | 3d filter for prevention of stroke |
WO2017100927A1 (en) | 2015-12-15 | 2017-06-22 | Neovasc Tiara Inc. | Transseptal delivery system |
CN113633435A (en) | 2016-01-29 | 2021-11-12 | 内奥瓦斯克迪亚拉公司 | Prosthetic valve for preventing outflow obstruction |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
CN109996581B (en) | 2016-11-21 | 2021-10-15 | 内奥瓦斯克迪亚拉公司 | Methods and systems for rapid retrieval of transcatheter heart valve delivery systems |
US10702381B2 (en) | 2016-12-01 | 2020-07-07 | Boston Scientific Scimed, Inc. | Heart valve remodeling device |
AU2018210334B2 (en) | 2017-01-20 | 2020-09-03 | W. L. Gore & Associates, Inc. | Embolic filter system |
EP3585305A1 (en) * | 2017-02-23 | 2020-01-01 | Boston Scientific Scimed, Inc. | Medical drain device |
US10588636B2 (en) * | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
US20180353280A1 (en) * | 2017-06-13 | 2018-12-13 | Dai Yamanouchi | Infarction prevention device and treatment method |
GB2563880B (en) * | 2017-06-28 | 2022-03-23 | Cook Medical Technologies Llc | Implantable medical device including valve member |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
CN107468379B (en) * | 2017-09-11 | 2023-09-08 | 姜正明 | Aortic valve stent delivery system and aortic valve system |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11382632B2 (en) * | 2018-06-27 | 2022-07-12 | Boston Scientific Scimed, Inc. | Vascular occlusion device |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
US11737872B2 (en) | 2018-11-08 | 2023-08-29 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US11304792B2 (en) * | 2019-02-13 | 2022-04-19 | Emboline, Inc. | Catheter with integrated embolic protection device |
JP7430732B2 (en) | 2019-03-08 | 2024-02-13 | ニオバスク ティアラ インコーポレイテッド | Retrievable prosthesis delivery system |
MX2021011069A (en) * | 2019-03-19 | 2021-10-13 | Carefusion 303 Inc | Needleless connector with in-line filter. |
US11602429B2 (en) | 2019-04-01 | 2023-03-14 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
CA3136334A1 (en) | 2019-04-10 | 2020-10-15 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
US11779742B2 (en) | 2019-05-20 | 2023-10-10 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
WO2020257643A1 (en) | 2019-06-20 | 2020-12-24 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
CN111938865B (en) * | 2020-07-31 | 2024-03-08 | 李云松 | Filter-related vein hyperplasia intima cutting catheter |
GB2607878B (en) | 2021-06-10 | 2024-07-10 | Cook Medical Technologies Llc | Implantable medical device and assembly |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3983581A (en) * | 1975-01-20 | 1976-10-05 | William W. Angell | Heart valve stent |
US5300086A (en) * | 1990-01-19 | 1994-04-05 | Pierre Gory | Device with a locating member for removably implanting a blood filter in a vein of the human body |
US6235044B1 (en) * | 1999-08-04 | 2001-05-22 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US20020151970A1 (en) * | 1999-02-10 | 2002-10-17 | Garrison Michi E. | Methods and devices for implanting cardiac valves |
US20030065356A1 (en) * | 1997-05-08 | 2003-04-03 | Embol-X, Inc. | Methods of protecting a patient from embolization during surgery |
US6582448B1 (en) * | 2000-12-21 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Vessel occlusion device for embolic protection system |
US6692513B2 (en) * | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US20050010285A1 (en) * | 1999-01-27 | 2005-01-13 | Lambrecht Gregory H. | Cardiac valve procedure methods and devices |
US20050015112A1 (en) * | 2000-01-27 | 2005-01-20 | Cohn William E. | Cardiac valve procedure methods and devices |
US20050075662A1 (en) * | 2003-07-18 | 2005-04-07 | Wesley Pedersen | Valvuloplasty catheter |
US20050137697A1 (en) * | 2003-12-23 | 2005-06-23 | Amr Salahieh | Leaflet engagement elements and methods for use thereof |
US20050137676A1 (en) * | 2003-12-19 | 2005-06-23 | Scimed Life Systems, Inc. | Venous valve apparatus, system, and method |
US20050187616A1 (en) * | 2003-11-13 | 2005-08-25 | Fidel Realyvasquez | Methods and apparatus for valve repair |
US20050240200A1 (en) * | 2004-04-23 | 2005-10-27 | Bjarne Bergheim | Method and system for cardiac valve delivery |
US20060074484A1 (en) * | 2004-10-02 | 2006-04-06 | Huber Christoph H | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
US20060136043A1 (en) * | 2004-12-22 | 2006-06-22 | Cully Edward H | Filament-wound implantable devices |
US20080269877A1 (en) * | 2007-02-05 | 2008-10-30 | Jenson Mark L | Systems and methods for valve delivery |
US20100131056A1 (en) * | 2007-05-02 | 2010-05-27 | Lapeyre Industries Llc | Mechanical prosthetic heart valve |
US20100168836A1 (en) * | 2003-02-21 | 2010-07-01 | Kassab Ghassan S | Balloon sizing of valve annulus for percutaneous valves |
US20100305604A1 (en) * | 2007-11-27 | 2010-12-02 | Gunnar Pah | Device for Filtering Blood |
US7959666B2 (en) * | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7988724B2 (en) * | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US8012198B2 (en) * | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
Family Cites Families (531)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3671979A (en) | 1969-09-23 | 1972-06-27 | Univ Utah | Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve |
US4291420A (en) | 1973-11-09 | 1981-09-29 | Medac Gesellschaft Fur Klinische Spezialpraparate Mbh | Artificial heart valve |
US7018407B1 (en) | 1981-10-29 | 2006-03-28 | Medtronic | Valve holder for tricuspid heart valve |
US5275622A (en) | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
DE3426300A1 (en) | 1984-07-17 | 1986-01-30 | Doguhan Dr.med. 6000 Frankfurt Baykut | TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS |
US4935030A (en) | 1985-06-17 | 1990-06-19 | Medtronic, Inc. | Mechanical heart valve prosthesis |
WO1988000459A1 (en) | 1986-07-17 | 1988-01-28 | Quotidian No. 100 Pty. Limited | Prosthetic venous valve |
US4872874A (en) | 1987-05-29 | 1989-10-10 | Taheri Syde A | Method and apparatus for transarterial aortic graft insertion and implantation |
JP2634431B2 (en) | 1987-06-26 | 1997-07-23 | ゼロックス コーポレーション | Paper feeder for copier |
JPS6483251A (en) | 1987-09-24 | 1989-03-29 | Terumo Corp | Instrument for securing inner diameter of cavity of tubular organ |
IT1218947B (en) | 1988-01-12 | 1990-04-24 | Sorin Biomedica Spa | CARDIAC VALVE PROSTHESIS |
SE8800244D0 (en) | 1988-01-27 | 1988-01-27 | Medical Innovation Ab | DEVICE FOR CUTTING OF LEFT FLAVORS |
US4994077A (en) * | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
US5609626A (en) | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
EP0474748B1 (en) | 1989-05-31 | 1995-01-25 | Baxter International Inc. | Biological valvular prosthesis |
CA2033195C (en) | 1989-06-19 | 1994-11-15 | Hugh H. Trout, Iii | Aortic graft and method for repairing aneurysm |
US5290300A (en) | 1989-07-31 | 1994-03-01 | Baxter International Inc. | Flexible suture guide and holder |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5578071A (en) | 1990-06-11 | 1996-11-26 | Parodi; Juan C. | Aortic graft |
AR246020A1 (en) | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
US5272909A (en) | 1991-04-25 | 1993-12-28 | Baxter International Inc. | Method and device for testing venous valves |
IT1245750B (en) * | 1991-05-24 | 1994-10-14 | Sorin Biomedica Emodialisi S R | CARDIAC VALVE PROSTHESIS, PARTICULARLY FOR REPLACING THE AORTIC VALVE |
US5370685A (en) | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5163953A (en) | 1992-02-10 | 1992-11-17 | Vince Dennis J | Toroidal artificial heart valve stent |
US5258023A (en) | 1992-02-12 | 1993-11-02 | Reger Medical Development, Inc. | Prosthetic heart valve |
US5234448A (en) | 1992-02-28 | 1993-08-10 | Shadyside Hospital | Method and apparatus for connecting and closing severed blood vessels |
US5332402A (en) | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5982645A (en) | 1992-08-25 | 1999-11-09 | Square D Company | Power conversion and distribution system |
US5265505A (en) | 1992-10-29 | 1993-11-30 | Frechette Eugene L | Turret-lathe coolant system |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US5972030A (en) | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
US5480423A (en) * | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5713950A (en) | 1993-11-01 | 1998-02-03 | Cox; James L. | Method of replacing heart valves using flexible tubes |
FR2718951B1 (en) | 1994-04-26 | 1996-07-26 | Perouse Implant Laboratoire | Tubular stent. |
US5554185A (en) | 1994-07-18 | 1996-09-10 | Block; Peter C. | Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same |
DE69523074T2 (en) * | 1994-07-29 | 2002-06-06 | Edwards Lifesciences Corp., Irvine | METHOD FOR TREATING IMPLANTABLE BIOLOGICAL TISSUES TO REDUCE CALCIFICATION |
FR2728457B1 (en) | 1994-12-21 | 1997-03-21 | Franceschi Claude | ARTIFICIAL VALVE FOR BLOOD VESSEL |
BE1009278A3 (en) | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as. |
CA2223160C (en) | 1995-06-07 | 2007-09-18 | St. Jude Medical, Inc. | Prosthetic heart valve with increased lumen |
US6402780B2 (en) | 1996-02-23 | 2002-06-11 | Cardiovascular Technologies, L.L.C. | Means and method of replacing a heart valve in a minimally invasive manner |
US5716370A (en) | 1996-02-23 | 1998-02-10 | Williamson, Iv; Warren | Means for replacing a heart valve in a minimally invasive manner |
US5928916A (en) | 1996-04-25 | 1999-07-27 | Medtronic, Inc. | Ionic attachment of biomolecules with a guanidino moiety to medical device surfaces |
CA2258732C (en) * | 1996-06-20 | 2006-04-04 | Sulzer Vascutek Ltd. | Prosthetic repair of body passages |
US5741326A (en) | 1996-07-15 | 1998-04-21 | Cordis Corporation | Low profile thermally set wrapped cover for a percutaneously deployed stent |
US6495334B1 (en) | 1996-07-19 | 2002-12-17 | Regents Of The University Of Minnesota | Recombinant Sef14 fimbrial protein from Salmonella |
US6764509B2 (en) | 1996-09-06 | 2004-07-20 | Carbomedics Inc. | Prosthetic heart valve with surface modification |
US5895419A (en) | 1996-09-30 | 1999-04-20 | St. Jude Medical, Inc. | Coated prosthetic cardiac device |
NL1004827C2 (en) * | 1996-12-18 | 1998-06-19 | Surgical Innovations Vof | Device for regulating blood circulation. |
US5879320A (en) | 1996-12-23 | 1999-03-09 | Cazenave; Craig Richard | Implantable vascular device |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US5735859A (en) | 1997-02-14 | 1998-04-07 | Cathco, Inc. | Distally attachable and releasable sheath for a stent delivery system |
WO1998038947A1 (en) | 1997-03-05 | 1998-09-11 | Scimed Life Systems, Inc. | Conformal laminate stent device |
US5928281A (en) * | 1997-03-27 | 1999-07-27 | Baxter International Inc. | Tissue heart valves |
US5961549A (en) * | 1997-04-03 | 1999-10-05 | Baxter International Inc. | Multi-leaflet bioprosthetic heart valve |
JP2001527440A (en) | 1997-04-11 | 2001-12-25 | トランスバスキュラー インコーポレイテッド | Method and device for myocardial penetrating direct coronary remodeling |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
EP2133030A1 (en) | 1997-06-27 | 2009-12-16 | The Trustees of Columbia University of the City of New York | Method and apparatus for circulatory valve repair |
DE19731834A1 (en) | 1997-07-24 | 1999-06-17 | Ernst Peter Prof Dr M Strecker | Implantation device |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
US6361545B1 (en) * | 1997-09-26 | 2002-03-26 | Cardeon Corporation | Perfusion filter catheter |
US5910170A (en) | 1997-12-17 | 1999-06-08 | St. Jude Medical, Inc. | Prosthetic heart valve stent utilizing mounting clips |
JP2002518066A (en) | 1997-12-29 | 2002-06-25 | ザ クリーブランド クリニック ファウンデーション | System for inserting bioprosthetic heart valves with minimal invasion |
US6530952B2 (en) | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US6074418A (en) | 1998-04-20 | 2000-06-13 | St. Jude Medical, Inc. | Driver tool for heart valve prosthesis fasteners |
US6007557A (en) * | 1998-04-29 | 1999-12-28 | Embol-X, Inc. | Adjustable blood filtration system |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
AU754156B2 (en) * | 1998-06-02 | 2002-11-07 | Cook Incorporated | Multiple-sided intraluminal medical device |
US6250308B1 (en) | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6641610B2 (en) | 1998-09-10 | 2003-11-04 | Percardia, Inc. | Valve designs for left ventricular conduits |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6921811B2 (en) | 1998-09-22 | 2005-07-26 | Biosurface Engineering Technologies, Inc. | Bioactive coating composition and methods |
US6355030B1 (en) | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
US6051014A (en) * | 1998-10-13 | 2000-04-18 | Embol-X, Inc. | Percutaneous filtration catheter for valve repair surgery and methods of use |
US6540780B1 (en) | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
CA2351671A1 (en) * | 1998-11-24 | 2000-06-08 | Regents Of The University Of Minnesota | Transgenic circulating endothelial cells |
US20040267349A1 (en) | 2003-06-27 | 2004-12-30 | Kobi Richter | Amorphous metal alloy medical devices |
US6736845B2 (en) | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
WO2000042951A1 (en) * | 1999-01-26 | 2000-07-27 | Edwards Lifesciences Corporation | Anatomical orifice sizers and methods of orifice sizing |
US6364905B1 (en) | 1999-01-27 | 2002-04-02 | Sulzer Carbomedics Inc. | Tri-composite, full root, stentless valve |
DE19904975A1 (en) | 1999-02-06 | 2000-09-14 | Impella Cardiotech Ag | Device for intravascular heart valve surgery |
US6666886B1 (en) | 1999-02-16 | 2003-12-23 | Regents Of The University Of Minnesota | Tissue equivalent approach to a tissue-engineered cardiovascular valve |
US6110201A (en) | 1999-02-18 | 2000-08-29 | Venpro | Bifurcated biological pulmonary valved conduit |
US6139575A (en) | 1999-04-02 | 2000-10-31 | Medtronic, Inc. | Hybrid mechanical heart valve prosthesis |
CA2369641C (en) * | 1999-04-09 | 2009-02-10 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US6752813B2 (en) * | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US7226467B2 (en) | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
US7604646B2 (en) * | 1999-04-09 | 2009-10-20 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US6666885B2 (en) | 1999-04-16 | 2003-12-23 | Carbomedics Inc. | Heart valve leaflet |
AU4242800A (en) | 1999-04-23 | 2000-11-10 | St. Jude Medical Cardiovascular Group, Inc. | Artificial heart valve attachment apparatus |
BR0010096A (en) | 1999-04-28 | 2002-02-19 | St Jude Medical | Cardiac valve prosthesis, kit, process to connect a cardiac valve prosthesis to a patient, and a fastener applicator to implant a cardiac valve prosthesis |
AU4673700A (en) | 1999-05-06 | 2000-11-21 | Venpro Corporation | Implant for restoring venous valvular function |
US6309417B1 (en) | 1999-05-12 | 2001-10-30 | Paul A. Spence | Heart valve and apparatus for replacement thereof |
US6790229B1 (en) | 1999-05-25 | 2004-09-14 | Eric Berreklouw | Fixing device, in particular for fixing to vascular wall tissue |
US7628803B2 (en) | 2001-02-05 | 2009-12-08 | Cook Incorporated | Implantable vascular device |
US6241763B1 (en) | 1999-06-08 | 2001-06-05 | William J. Drasler | In situ venous valve device and method of formation |
SE514718C2 (en) * | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US7192442B2 (en) | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6997951B2 (en) | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US20030055492A1 (en) * | 1999-08-20 | 2003-03-20 | Shaolian Samuel M. | Transluminally implantable venous valve |
DE10084973T1 (en) | 1999-08-27 | 2002-07-25 | Kimberly Clark Co | Absorbent object with a folded, expandable, absorbent layer |
US6315793B1 (en) | 1999-09-08 | 2001-11-13 | Medical Carbon Research Institute, Llc | Prosthetic venous valves |
DE19945587A1 (en) | 1999-09-23 | 2001-05-10 | Co Don Ag | Procedure for inserting implants into human organs |
US6312447B1 (en) | 1999-10-13 | 2001-11-06 | The General Hospital Corporation | Devices and methods for percutaneous mitral valve repair |
US6626930B1 (en) | 1999-10-21 | 2003-09-30 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair method and apparatus |
JP2001120582A (en) | 1999-10-22 | 2001-05-08 | Gunze Ltd | Artificial cardiac valve and method of manufacturing the same |
US6926730B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US6723123B1 (en) | 1999-11-10 | 2004-04-20 | Impsa International Incorporated | Prosthetic heart valve |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
FR2800984B1 (en) * | 1999-11-17 | 2001-12-14 | Jacques Seguin | DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6709457B1 (en) | 1999-11-24 | 2004-03-23 | St. Jude Medical, Inc. | Attachment of suture cuff to prosthetic heart valve |
SE514886C2 (en) | 1999-12-14 | 2001-05-14 | Jcl Technic Ab | Vascular valve, such as heart valve, and process for its manufacture |
MXPA02006359A (en) | 1999-12-24 | 2002-11-29 | Toray Industries | Catheter with balloon. |
US6942694B2 (en) | 2000-01-14 | 2005-09-13 | Viacor, Inc. | Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same |
WO2001055473A1 (en) * | 2000-01-25 | 2001-08-02 | Boston Scientific Limited | Manufacturing medical devices by vapor deposition |
CA2397377A1 (en) | 2000-01-25 | 2001-08-02 | Edwards Lifesciences Corporation | Bioactive coatings to prevent tissue overgrowth on artificial heart valves |
WO2001054624A1 (en) | 2000-01-27 | 2001-08-02 | 3F Therapeutics, Inc. | Prosthetic heart valve |
US6872226B2 (en) | 2001-01-29 | 2005-03-29 | 3F Therapeutics, Inc. | Method of cutting material for use in implantable medical device |
US6989028B2 (en) * | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
US7011682B2 (en) | 2000-01-31 | 2006-03-14 | Edwards Lifesciences Ag | Methods and apparatus for remodeling an extravascular tissue structure |
US6821297B2 (en) | 2000-02-02 | 2004-11-23 | Robert V. Snyders | Artificial heart valve, implantation instrument and method therefor |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US20050070999A1 (en) | 2000-02-02 | 2005-03-31 | Spence Paul A. | Heart valve repair apparatus and methods |
US20030229393A1 (en) | 2001-03-15 | 2003-12-11 | Kutryk Michael J. B. | Medical device with coating that promotes cell adherence and differentiation |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6652583B2 (en) | 2000-04-07 | 2003-11-25 | Rhode Island Hospital | Cardiac valve replacement |
CA2407439C (en) * | 2000-04-27 | 2008-07-08 | Axel Haverich | Individual venous valve prosthesis |
US7083628B2 (en) | 2002-09-03 | 2006-08-01 | Edwards Lifesciences Corporation | Single catheter mitral valve repair device and method for use |
US6869444B2 (en) | 2000-05-22 | 2005-03-22 | Shlomo Gabbay | Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve |
US8366769B2 (en) | 2000-06-01 | 2013-02-05 | Edwards Lifesciences Corporation | Low-profile, pivotable heart valve sewing ring |
US6805711B2 (en) | 2000-06-02 | 2004-10-19 | 3F Therapeutics, Inc. | Expandable medical implant and percutaneous delivery |
US20050043757A1 (en) | 2000-06-12 | 2005-02-24 | Michael Arad | Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof |
AU2001268535A1 (en) | 2000-06-20 | 2002-01-02 | Starion Instruments, Inc. | Devices and methods for repair of valves in the human body |
US6840246B2 (en) * | 2000-06-20 | 2005-01-11 | University Of Maryland, Baltimore | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
WO2002000099A2 (en) | 2000-06-23 | 2002-01-03 | Viacor Incorporated | Automated annular plication for mitral valve repair |
US6676698B2 (en) * | 2000-06-26 | 2004-01-13 | Rex Medicol, L.P. | Vascular device with valve for approximating vessel wall |
US6695878B2 (en) | 2000-06-26 | 2004-02-24 | Rex Medical, L.P. | Vascular device for valve leaflet apposition |
SE0002514D0 (en) | 2000-06-30 | 2000-06-30 | Pacesetter Ab | Medical device |
EP1401358B1 (en) | 2000-06-30 | 2016-08-17 | Medtronic, Inc. | Apparatus for performing a procedure on a cardiac valve |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US7077861B2 (en) | 2000-07-06 | 2006-07-18 | Medtentia Ab | Annuloplasty instrument |
US6695817B1 (en) * | 2000-07-11 | 2004-02-24 | Icu Medical, Inc. | Medical valve with positive flow characteristics |
SE0002878D0 (en) | 2000-08-11 | 2000-08-11 | Kimblad Ola | Device and method of treatment of atrioventricular regurgitation |
US6635085B1 (en) | 2000-08-17 | 2003-10-21 | Carbomedics Inc. | Heart valve stent with alignment posts |
US6572652B2 (en) | 2000-08-29 | 2003-06-03 | Venpro Corporation | Method and devices for decreasing elevated pulmonary venous pressure |
AU2001287144A1 (en) * | 2000-09-07 | 2002-03-22 | Viacor, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
WO2002022054A1 (en) | 2000-09-12 | 2002-03-21 | Gabbay S | Valvular prosthesis and method of using same |
US20060142848A1 (en) | 2000-09-12 | 2006-06-29 | Shlomo Gabbay | Extra-anatomic aortic valve placement |
DE10046550A1 (en) | 2000-09-19 | 2002-03-28 | Adiam Life Science Ag | Prosthetic mitral heart valve consists of support housing with base ring and two stanchions |
US20050228422A1 (en) | 2002-11-26 | 2005-10-13 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US20060106456A9 (en) | 2002-10-01 | 2006-05-18 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
WO2004030568A2 (en) | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
US6893459B1 (en) | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
US8784482B2 (en) | 2000-09-20 | 2014-07-22 | Mvrx, Inc. | Method of reshaping a heart valve annulus using an intravascular device |
US20060106278A1 (en) | 2004-05-14 | 2006-05-18 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system |
US20060106279A1 (en) | 2004-05-14 | 2006-05-18 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant having an adjustable bridge stop |
US8956407B2 (en) | 2000-09-20 | 2015-02-17 | Mvrx, Inc. | Methods for reshaping a heart valve annulus using a tensioning implant |
US7527646B2 (en) | 2000-09-20 | 2009-05-05 | Ample Medical, Inc. | Devices, systems, and methods for retaining a native heart valve leaflet |
US6461382B1 (en) | 2000-09-22 | 2002-10-08 | Edwards Lifesciences Corporation | Flexible heart valve having moveable commissures |
WO2002026168A2 (en) | 2000-09-29 | 2002-04-04 | Tricardia, Llc | Venous valvuloplasty device |
US6602288B1 (en) | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
DE10049865B8 (en) | 2000-10-09 | 2008-10-30 | Universitätsklinikum Freiburg | Device for removing an aortic valve on the human heart by means of a minimally invasive surgical procedure |
DE10050092A1 (en) * | 2000-10-09 | 2002-04-11 | Adiam Life Science Ag | Prosthetic mitral valve comprises base and valve flaps which have core which is more rigid than their surface layer |
US6918917B1 (en) | 2000-10-10 | 2005-07-19 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
US6913608B2 (en) | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US7070618B2 (en) | 2000-10-25 | 2006-07-04 | Viacor, Inc. | Mitral shield |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US6974476B2 (en) * | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
US6953332B1 (en) | 2000-11-28 | 2005-10-11 | St. Jude Medical, Inc. | Mandrel for use in forming valved prostheses having polymer leaflets by dip coating |
US6730122B1 (en) | 2000-11-28 | 2004-05-04 | St. Jude Medical, Inc. | Prosthetic heart valve with increased lumen |
AU2002236640A1 (en) * | 2000-12-15 | 2002-06-24 | Viacor, Inc. | Apparatus and method for replacing aortic valve |
US6716244B2 (en) | 2000-12-20 | 2004-04-06 | Carbomedics, Inc. | Sewing cuff assembly for heart valves |
US6964682B2 (en) | 2000-12-21 | 2005-11-15 | Edwards Lifesciences Corporation | Heart valve holder that resist suture looping |
US6966925B2 (en) | 2000-12-21 | 2005-11-22 | Edwards Lifesciences Corporation | Heart valve holder and method for resisting suture looping |
US6669725B2 (en) | 2000-12-28 | 2003-12-30 | Centerpulse Biologics Inc. | Annuloplasty ring for regeneration of diseased or damaged heart valve annulus |
US7510576B2 (en) | 2001-01-30 | 2009-03-31 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
US20050182483A1 (en) | 2004-02-11 | 2005-08-18 | Cook Incorporated | Percutaneously placed prosthesis with thromboresistant valve portion |
US6790231B2 (en) | 2001-02-05 | 2004-09-14 | Viacor, Inc. | Apparatus and method for reducing mitral regurgitation |
CN100342829C (en) | 2001-02-05 | 2007-10-17 | 维亚科公司 | Method and apparatus for improving mitral valve function |
US20020107531A1 (en) | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
US6786924B2 (en) | 2001-03-15 | 2004-09-07 | Medtronic, Inc. | Annuloplasty band and method |
US6916338B2 (en) | 2001-03-16 | 2005-07-12 | Mayo Foundation For Medical Education And Research | Synthetic leaflets for heart valve repair or replacement |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
WO2002076284A2 (en) | 2001-03-23 | 2002-10-03 | Viacor, Inc. | Method and apparatus for reducing mitral regurgitation |
AUPR389201A0 (en) | 2001-03-23 | 2001-04-12 | Lane, Rodney James | Improvements in design of external vendus valve stents for the correction fo incompetent vendods valves |
US7186264B2 (en) | 2001-03-29 | 2007-03-06 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US6958076B2 (en) | 2001-04-16 | 2005-10-25 | Biomedical Research Associates Inc. | Implantable venous valve |
US7037334B1 (en) | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US20060069429A1 (en) | 2001-04-24 | 2006-03-30 | Spence Paul A | Tissue fastening systems and methods utilizing magnetic guidance |
US20050125011A1 (en) | 2001-04-24 | 2005-06-09 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
US6619291B2 (en) * | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
US20040193253A1 (en) | 2001-04-30 | 2004-09-30 | Thorpe Patricia E | Replacement venous valve |
DE10121210B4 (en) | 2001-04-30 | 2005-11-17 | Universitätsklinikum Freiburg | Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production |
US6682558B2 (en) | 2001-05-10 | 2004-01-27 | 3F Therapeutics, Inc. | Delivery system for a stentless valve bioprosthesis |
US6800090B2 (en) * | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US6676702B2 (en) * | 2001-05-14 | 2004-01-13 | Cardiac Dimensions, Inc. | Mitral valve therapy assembly and method |
US6858039B2 (en) * | 2002-07-08 | 2005-02-22 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring having a posterior bow |
ITMI20011012A1 (en) | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | ANNULAR PROSTHESIS FOR MITRAL VALVE |
US6936067B2 (en) | 2001-05-17 | 2005-08-30 | St. Jude Medical Inc. | Prosthetic heart valve with slit stent |
US20020173811A1 (en) | 2001-05-21 | 2002-11-21 | Hosheng Tu | Apparatus and methods for valve removal |
US7201761B2 (en) * | 2001-06-29 | 2007-04-10 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) * | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
DE60217507T2 (en) | 2001-07-19 | 2007-11-15 | Nymox Corp., Saint-Laurent | PEPTIDES FOR THE TREATMENT OF TUMORS AND OTHER STATES THAT REQUIRE THE REMOVAL OR DESTROYING OF CELLS |
US7547322B2 (en) | 2001-07-19 | 2009-06-16 | The Cleveland Clinic Foundation | Prosthetic valve and method for making same |
FR2828091B1 (en) * | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US6726716B2 (en) | 2001-08-24 | 2004-04-27 | Edwards Lifesciences Corporation | Self-molding annuloplasty ring |
US6749630B2 (en) | 2001-08-28 | 2004-06-15 | Edwards Lifesciences Corporation | Tricuspid ring and template |
US6723122B2 (en) | 2001-08-30 | 2004-04-20 | Edwards Lifesciences Corporation | Container and method for storing and delivering minimally-invasive heart valves |
CA2455444A1 (en) | 2001-10-01 | 2003-04-10 | Ample Medical, Inc. | Methods and devices for heart valve treatments |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US7144363B2 (en) | 2001-10-16 | 2006-12-05 | Extensia Medical, Inc. | Systems for heart treatment |
US20060020336A1 (en) * | 2001-10-23 | 2006-01-26 | Liddicoat John R | Automated annular plication for mitral valve repair |
US6726715B2 (en) | 2001-10-23 | 2004-04-27 | Childrens Medical Center Corporation | Fiber-reinforced heart valve prosthesis |
US7052487B2 (en) | 2001-10-26 | 2006-05-30 | Cohn William E | Method and apparatus for reducing mitral regurgitation |
US20040044403A1 (en) | 2001-10-30 | 2004-03-04 | Joyce Bischoff | Tissue-engineered vascular structures |
US7311729B2 (en) | 2002-01-30 | 2007-12-25 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6949122B2 (en) | 2001-11-01 | 2005-09-27 | Cardiac Dimensions, Inc. | Focused compression mitral valve device and method |
US6824562B2 (en) | 2002-05-08 | 2004-11-30 | Cardiac Dimensions, Inc. | Body lumen device anchor, device and assembly |
US6805710B2 (en) | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US6719784B2 (en) | 2001-11-21 | 2004-04-13 | Scimed Life Systems, Inc. | Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis |
US20050228479A1 (en) | 2001-11-29 | 2005-10-13 | Cook Incorporated | Medical device delivery system |
US7179282B2 (en) * | 2001-12-05 | 2007-02-20 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6908478B2 (en) | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
US6793673B2 (en) | 2002-12-26 | 2004-09-21 | Cardiac Dimensions, Inc. | System and method to effect mitral valve annulus of a heart |
US6976995B2 (en) | 2002-01-30 | 2005-12-20 | Cardiac Dimensions, Inc. | Fixed length anchor and pull mitral valve device and method |
US6978176B2 (en) | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US6755857B2 (en) | 2001-12-12 | 2004-06-29 | Sulzer Carbomedics Inc. | Polymer heart valve with perforated stent and sewing cuff |
EP1465555B1 (en) | 2001-12-21 | 2015-05-06 | QuickRing Medical Technologies Ltd. | Implantation system for annuloplasty rings |
US6951573B1 (en) | 2001-12-22 | 2005-10-04 | Dilling Emery W | Prosthetic aortic valve |
US20030120340A1 (en) | 2001-12-26 | 2003-06-26 | Jan Liska | Mitral and tricuspid valve repair |
US7201771B2 (en) | 2001-12-27 | 2007-04-10 | Arbor Surgical Technologies, Inc. | Bioprosthetic heart valve |
US6881224B2 (en) | 2001-12-28 | 2005-04-19 | St. Jude Medical, Inc. | Fatigue test for prosthetic stent |
US7033390B2 (en) * | 2002-01-02 | 2006-04-25 | Medtronic, Inc. | Prosthetic heart valve system |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US20030130729A1 (en) | 2002-01-04 | 2003-07-10 | David Paniagua | Percutaneously implantable replacement heart valve device and method of making same |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
CA2688796A1 (en) | 2002-01-11 | 2003-07-10 | Edwards Lifesciences Ag. | Delayed memory device |
US7125420B2 (en) | 2002-02-05 | 2006-10-24 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
WO2003070124A2 (en) | 2002-02-20 | 2003-08-28 | Osse Francisco J | Venous bi-valve |
DE10208202A1 (en) | 2002-02-26 | 2003-09-11 | Karlsruhe Forschzent | vein graft |
US6974464B2 (en) | 2002-02-28 | 2005-12-13 | 3F Therapeutics, Inc. | Supportless atrioventricular heart valve and minimally invasive delivery systems thereof |
US7048754B2 (en) | 2002-03-01 | 2006-05-23 | Evalve, Inc. | Suture fasteners and methods of use |
US6716241B2 (en) | 2002-03-05 | 2004-04-06 | John G. Wilder | Venous valve and graft combination |
US7004958B2 (en) * | 2002-03-06 | 2006-02-28 | Cardiac Dimensions, Inc. | Transvenous staples, assembly and method for mitral valve repair |
US6797001B2 (en) | 2002-03-11 | 2004-09-28 | Cardiac Dimensions, Inc. | Device, assembly and method for mitral valve repair |
US6719786B2 (en) | 2002-03-18 | 2004-04-13 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7163556B2 (en) * | 2002-03-21 | 2007-01-16 | Providence Health System - Oregon | Bioprosthesis and method for suturelessly making same |
US7094244B2 (en) * | 2002-03-26 | 2006-08-22 | Edwards Lifesciences Corporation | Sequential heart valve leaflet repair device and method of use |
US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US7160320B2 (en) | 2002-04-16 | 2007-01-09 | The International Heart Institute Of Montana Foundation | Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support |
US7125418B2 (en) | 2002-04-16 | 2006-10-24 | The International Heart Institute Of Montana Foundation | Sigmoid valve and method for its percutaneous implantation |
DE10217559B4 (en) | 2002-04-19 | 2004-02-19 | Universitätsklinikum Freiburg | Device for minimally invasive, intravascular aortic valve extraction |
FR2838631B1 (en) | 2002-04-23 | 2004-12-24 | Engeneering And Technological | METHOD FOR PRODUCING AN AORTIC OR MITRAL HEART VALVE PROSTHESIS AND AORTIC OR MITRAL HEART VALVE PROSTHESIS THUS OBTAINED |
US6761735B2 (en) | 2002-04-25 | 2004-07-13 | Medtronic, Inc. | Heart valve fixation process and apparatus |
AU2003234505A1 (en) | 2002-05-03 | 2003-11-17 | The General Hospital Corporation | Involuted endovascular valve and method of construction |
CA2950492C (en) | 2002-05-08 | 2018-12-04 | Cardiac Dimensions Pty. Ltd. | Device and method for modifying the shape of a body organ |
US7351256B2 (en) | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US20030225447A1 (en) * | 2002-05-10 | 2003-12-04 | Majercak David Christopher | Method of making a medical device having a thin wall tubular membrane over a structural frame |
US20030229394A1 (en) | 2002-06-06 | 2003-12-11 | Ogle Matthew F. | Processed tissue for medical device formation |
WO2003105667A2 (en) | 2002-06-12 | 2003-12-24 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US7666193B2 (en) | 2002-06-13 | 2010-02-23 | Guided Delivery Sytems, Inc. | Delivery devices and methods for heart valve repair |
US7753922B2 (en) | 2003-09-04 | 2010-07-13 | Guided Delivery Systems, Inc. | Devices and methods for cardiac annulus stabilization and treatment |
EP1530441B1 (en) | 2002-06-13 | 2017-08-02 | Ancora Heart, Inc. | Devices and methods for heart valve repair |
US20040243227A1 (en) | 2002-06-13 | 2004-12-02 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8287555B2 (en) | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20050107811A1 (en) | 2002-06-13 | 2005-05-19 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US20050216078A1 (en) | 2002-06-13 | 2005-09-29 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7758637B2 (en) | 2003-02-06 | 2010-07-20 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7753858B2 (en) * | 2002-06-13 | 2010-07-13 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7959674B2 (en) | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US7578843B2 (en) * | 2002-07-16 | 2009-08-25 | Medtronic, Inc. | Heart valve prosthesis |
US7172625B2 (en) * | 2002-07-16 | 2007-02-06 | Medtronic, Inc. | Suturing rings for implantable heart valve prostheses |
US6761734B2 (en) | 2002-07-22 | 2004-07-13 | William S. Suhr | Segmented balloon catheter for stenting bifurcation lesions |
US8172856B2 (en) | 2002-08-02 | 2012-05-08 | Cedars-Sinai Medical Center | Methods and apparatus for atrioventricular valve repair |
US20040024452A1 (en) * | 2002-08-02 | 2004-02-05 | Kruse Steven D. | Valved prostheses with preformed tissue leaflets |
DE20321838U1 (en) | 2002-08-13 | 2011-02-10 | JenaValve Technology Inc., Wilmington | Device for anchoring and aligning heart valve prostheses |
EP1534146B1 (en) | 2002-08-13 | 2008-01-23 | The General Hospital Corporation | Cardiac devices for percutaneous repair of atrioventricular valves |
US7041132B2 (en) * | 2002-08-16 | 2006-05-09 | 3F Therapeutics, Inc, | Percutaneously delivered heart valve and delivery means thereof |
US20040092858A1 (en) | 2002-08-28 | 2004-05-13 | Heart Leaflet Technologies, Inc. | Leaflet valve |
US6875231B2 (en) | 2002-09-11 | 2005-04-05 | 3F Therapeutics, Inc. | Percutaneously deliverable heart valve |
AU2003263454A1 (en) * | 2002-09-19 | 2004-04-08 | Petrus Besselink | Vascular filter with improved strength and flexibility |
CO5500017A1 (en) | 2002-09-23 | 2005-03-31 | 3F Therapeutics Inc | MITRAL PROTESTIC VALVE |
US20040059412A1 (en) | 2002-09-25 | 2004-03-25 | Lytle Thomas William | Heart valve holder |
US20040060161A1 (en) | 2002-09-27 | 2004-04-01 | David Leal | Methods of forming a heart valve stent |
CA2501750A1 (en) | 2002-10-10 | 2004-04-22 | The Cleveland Clinic Foundation | Method and apparatus for replacing a mitral valve with a stentless bioprosthetic valve having chordae |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US8979923B2 (en) | 2002-10-21 | 2015-03-17 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US8460371B2 (en) | 2002-10-21 | 2013-06-11 | Mitralign, Inc. | Method and apparatus for performing catheter-based annuloplasty using local plications |
EP1553897A1 (en) | 2002-10-24 | 2005-07-20 | Boston Scientific Limited | Venous valve apparatus and method |
US20040082910A1 (en) | 2002-10-29 | 2004-04-29 | Constantz Brent R. | Devices and methods for treating aortic valve stenosis |
GB0225075D0 (en) | 2002-10-29 | 2002-12-04 | Smiths Group Plc | Valves |
US7247134B2 (en) | 2002-11-12 | 2007-07-24 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
ATE516756T1 (en) | 2002-11-12 | 2011-08-15 | Edwards Lifesciences Ag | DEVICES FOR TREATING THE HEART VALVE |
JP4568116B2 (en) | 2002-11-13 | 2010-10-27 | ビアカー・インコーポレーテッド | Heart valve treatment method and apparatus |
US7255706B2 (en) | 2002-11-13 | 2007-08-14 | Rosengart Todd K | Apparatus and method for cutting a heart valve |
US20040097979A1 (en) | 2002-11-14 | 2004-05-20 | Oleg Svanidze | Aortic valve implantation device |
WO2004045378A2 (en) | 2002-11-15 | 2004-06-03 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Method and device for catheter-based repair of cardiac valves |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
FR2847151B1 (en) | 2002-11-15 | 2005-01-21 | Claude Mialhe | OCCLUSIVE DEVICE WITH MEDICAL OR SURGICAL DESTINATION |
US6945978B1 (en) | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
US20040122515A1 (en) | 2002-11-21 | 2004-06-24 | Xi Chu | Prosthetic valves and methods of manufacturing |
US7316708B2 (en) | 2002-12-05 | 2008-01-08 | Cardiac Dimensions, Inc. | Medical device delivery system |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US20040133240A1 (en) | 2003-01-07 | 2004-07-08 | Cardiac Dimensions, Inc. | Electrotherapy system, device, and method for treatment of cardiac valve dysfunction |
US6830585B1 (en) | 2003-01-14 | 2004-12-14 | 3F Therapeutics, Inc. | Percutaneously deliverable heart valve and methods of implantation |
US6997950B2 (en) * | 2003-01-16 | 2006-02-14 | Chawla Surendra K | Valve repair device |
US6746463B1 (en) | 2003-01-27 | 2004-06-08 | Scimed Life Systems, Inc | Device for percutaneous cutting and dilating a stenosis of the aortic valve |
US7220271B2 (en) | 2003-01-30 | 2007-05-22 | Ev3 Inc. | Embolic filters having multiple layers and controlled pore size |
EP1594420A2 (en) | 2003-01-31 | 2005-11-16 | Koninklijke Philips Electronics N.V. | Magnetic resonance compatible stent |
US7314485B2 (en) | 2003-02-03 | 2008-01-01 | Cardiac Dimensions, Inc. | Mitral valve device using conditioned shape memory alloy |
US20040158321A1 (en) | 2003-02-12 | 2004-08-12 | Cardiac Dimensions, Inc. | Method of implanting a mitral valve therapy device |
US20040254600A1 (en) | 2003-02-26 | 2004-12-16 | David Zarbatany | Methods and devices for endovascular mitral valve correction from the left coronary sinus |
WO2004075789A2 (en) | 2003-02-26 | 2004-09-10 | Cook Incorporated | PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING |
EP1603492B1 (en) | 2003-03-12 | 2009-12-23 | Cook Incorporated | Prosthetic valve that permits retrograde flow |
US7381210B2 (en) | 2003-03-14 | 2008-06-03 | Edwards Lifesciences Corporation | Mitral valve repair system and method for use |
WO2004082528A2 (en) | 2003-03-17 | 2004-09-30 | Cook Incorporated | Vascular valve with removable support component |
US7988679B2 (en) | 2003-03-18 | 2011-08-02 | Navilyst Medical, Inc. | Pressure responsive slit valve assembly for a plurality of fluids and uses thereof |
US7399315B2 (en) | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
EP1608297A2 (en) | 2003-03-18 | 2005-12-28 | St. Jude Medical, Inc. | Body tissue remodeling apparatus |
WO2004082530A2 (en) | 2003-03-19 | 2004-09-30 | Cook Incorporated | Delivery systems for deploying expandable intraluminal medical devices |
ES2311148T3 (en) | 2003-03-20 | 2009-02-01 | Aortech International Plc | VALVE. |
CH696185A5 (en) | 2003-03-21 | 2007-02-15 | Afksendiyos Kalangos | Intraparietal reinforcement for aortic valve and reinforced valve has rod inserted in biological tissue or organic prosthesis with strut fixed to one end |
SE0300854D0 (en) | 2003-03-26 | 2003-03-26 | Oeyvind Reitan | Device for the treatment of a heart valve insufficiency |
KR100466839B1 (en) | 2003-03-28 | 2005-01-17 | 주식회사 사이언씨티 | Aortic valve Repairing Apparatus Sets and Treatment Method Using The Same |
WO2004089250A1 (en) | 2003-03-30 | 2004-10-21 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US20050075659A1 (en) | 2003-03-30 | 2005-04-07 | Fidel Realyvasquez | Apparatus and methods for minimally invasive valve surgery |
WO2004089253A1 (en) | 2003-04-01 | 2004-10-21 | Cook Incorporated | Percutaneously deployed vascular valves |
WO2004091449A1 (en) | 2003-04-08 | 2004-10-28 | Cook Incorporated | Intraluminal support device with graft |
US7159593B2 (en) | 2003-04-17 | 2007-01-09 | 3F Therapeutics, Inc. | Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US7530995B2 (en) | 2003-04-17 | 2009-05-12 | 3F Therapeutics, Inc. | Device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US8083707B2 (en) | 2003-04-17 | 2011-12-27 | Tosaya Carol A | Non-contact damage-free ultrasonic cleaning of implanted or natural structures having moving parts and located in a living body |
US6945996B2 (en) | 2003-04-18 | 2005-09-20 | Sedransk Kyra L | Replacement mitral valve |
US7175656B2 (en) | 2003-04-18 | 2007-02-13 | Alexander Khairkhahan | Percutaneous transcatheter heart valve replacement |
US20040210240A1 (en) | 2003-04-21 | 2004-10-21 | Sean Saint | Method and repair device for treating mitral valve insufficiency |
WO2004093745A1 (en) | 2003-04-23 | 2004-11-04 | Cook Incorporated | Devices kits, and methods for placing multiple intraluminal medical devices in a body vessel |
EP1615595B1 (en) | 2003-04-24 | 2009-10-21 | Cook Incorporated | Artificial valve prosthesis with improved flow dynamics |
US20040267357A1 (en) | 2003-04-30 | 2004-12-30 | Allen Jeffrey W. | Cardiac valve modification method and device |
DE602004023350D1 (en) * | 2003-04-30 | 2009-11-12 | Medtronic Vascular Inc | Percutaneous inserted provisional valve |
US20040220654A1 (en) | 2003-05-02 | 2004-11-04 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US20040220657A1 (en) | 2003-05-02 | 2004-11-04 | Cardiac Dimensions, Inc., A Washington Corporation | Tissue shaping device with conformable anchors |
US20040225356A1 (en) | 2003-05-09 | 2004-11-11 | Frater Robert W. | Flexible heart valve |
US7128759B2 (en) | 2003-05-19 | 2006-10-31 | Cook Incorporated | Implantable medical device with constrained expansion |
WO2004103223A1 (en) | 2003-05-20 | 2004-12-02 | The Cleveland Clinic Foundation | Apparatus and methods for repair of a cardiac valve |
AU2004243029B2 (en) | 2003-05-27 | 2009-12-03 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US7628804B2 (en) | 2003-05-28 | 2009-12-08 | Cook Incorporated | Prosthetic valve with vessel engaging member |
US7007396B2 (en) | 2003-05-29 | 2006-03-07 | Plc Medical Systems, Inc. | Replacement heart valve sizing device |
US7351259B2 (en) * | 2003-06-05 | 2008-04-01 | Cardiac Dimensions, Inc. | Device, system and method to affect the mitral valve annulus of a heart |
TW590007U (en) | 2003-06-06 | 2004-06-01 | Univ Tamkang | Tri-leaflet mechanical heart valve |
WO2005004753A1 (en) | 2003-06-09 | 2005-01-20 | 3F Therapeutics, Inc. | Atrioventricular heart valve and minimally invasive delivery systems thereof |
US7537600B2 (en) * | 2003-06-12 | 2009-05-26 | Boston Scientific Scimed, Inc. | Valved embolic protection filter |
WO2004112652A2 (en) | 2003-06-20 | 2004-12-29 | Medtronic Vascular, Inc. | Device, system, and method for contracting tissue in a mammalian body |
US7316706B2 (en) | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
US7537592B2 (en) | 2003-06-20 | 2009-05-26 | Plc Medical Systems, Inc. | Endovascular tissue removal device |
EP1648346A4 (en) | 2003-06-20 | 2006-10-18 | Medtronic Vascular Inc | Valve annulus reduction system |
WO2004112582A2 (en) | 2003-06-20 | 2004-12-29 | Plc Medical Systems, Inc. | Endovascular tissue removal device |
US20040260394A1 (en) | 2003-06-20 | 2004-12-23 | Medtronic Vascular, Inc. | Cardiac valve annulus compressor system |
US8052751B2 (en) | 2003-07-02 | 2011-11-08 | Flexcor, Inc. | Annuloplasty rings for repairing cardiac valves |
US7429269B2 (en) | 2003-07-08 | 2008-09-30 | Ventor Technologies Ltd. | Aortic prosthetic devices |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
WO2005007037A1 (en) | 2003-07-11 | 2005-01-27 | Vedic Biotechnology, Inc. | Selective annuloplasty for atrio-ventricular heart valve regurgitation and devices therefor |
NZ527025A (en) | 2003-07-16 | 2007-01-26 | David Peter Shaw | Prosthetic valves for medical application |
WO2005007018A2 (en) | 2003-07-16 | 2005-01-27 | The Regents Of The University Of California | Thin-film metal alloy biomedical implantable devices |
ATE460201T1 (en) | 2003-07-17 | 2010-03-15 | Cordis Corp | DEVICES FOR THE PERCUTANE TREATMENT OF AORTIC VALVE STENSOSES |
WO2005007036A1 (en) | 2003-07-18 | 2005-01-27 | Brivant Research & Development Limited | A device for correcting inversion of the leaflets of a leaflet valve in the heart |
WO2005018507A2 (en) | 2003-07-18 | 2005-03-03 | Ev3 Santa Rosa, Inc. | Remotely activated mitral annuloplasty system and methods |
ATE442107T1 (en) | 2003-07-21 | 2009-09-15 | Univ Pennsylvania | PERCUTANE HEART VALVE |
JP4002293B2 (en) | 2003-07-22 | 2007-10-31 | コラゾン テクノロジーズ インコーポレーティッド | Apparatus and method for treating aortic valve stenosis |
WO2005009286A2 (en) | 2003-07-23 | 2005-02-03 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US7204255B2 (en) | 2003-07-28 | 2007-04-17 | Plc Medical Systems, Inc. | Endovascular tissue removal device |
DE10334868B4 (en) | 2003-07-29 | 2013-10-17 | Pfm Medical Ag | Implantable device as a replacement organ valve, its manufacturing process and basic body and membrane element for it |
US7951121B2 (en) * | 2003-07-30 | 2011-05-31 | Navilyst Medical, Inc. | Pressure actuated valve with improved slit configuration |
WO2005011534A1 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve devices and methods of making such devices |
WO2005011535A2 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
FR2858543B1 (en) | 2003-08-08 | 2006-02-03 | Assist Publ Hopitaux De Paris | AORTIC AND ANCILLARY RING FOR ITS INSTALLATION |
DE10340265A1 (en) | 2003-08-29 | 2005-04-07 | Sievers, Hans-Hinrich, Prof. Dr.med. | Prosthesis for the replacement of the aortic and / or mitral valve of the heart |
US20050049692A1 (en) | 2003-09-02 | 2005-03-03 | Numamoto Michael J. | Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
WO2005027797A1 (en) | 2003-09-23 | 2005-03-31 | Ersin Erek | A mitral web apparatus for mitral valve insufficiencies |
EG24012A (en) | 2003-09-24 | 2008-03-23 | Wael Mohamed Nabil Lotfy | Valved balloon stent |
US20050075725A1 (en) | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
US20050075730A1 (en) | 2003-10-06 | 2005-04-07 | Myers Keith E. | Minimally invasive valve replacement system |
EP1684671B1 (en) | 2003-10-06 | 2020-09-30 | Medtronic 3F Therapeutics, Inc. | Minimally invasive valve replacement system |
US7004176B2 (en) | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
CA2542658A1 (en) | 2003-10-17 | 2005-05-06 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US7258698B2 (en) | 2003-10-17 | 2007-08-21 | Medtronic, Inc. | Prosthetic heart valve sizer assembly with flexible sizer body |
ITBO20030631A1 (en) | 2003-10-23 | 2005-04-24 | Roberto Erminio Parravicini | VALVULAR PROSTHETIC EQUIPMENT, IN PARTICULAR FOR HEART APPLICATIONS. |
DE10350287A1 (en) | 2003-10-24 | 2005-05-25 | Deutsche Institute für Textil- und Faserforschung Stuttgart - Stiftung des öffentlichen Rechts | Cardiovascular implant, for use as a vascular or heart valve replacement, comprises a non-resorbable polymer formed as a microfiber fleece that allows colonization by a cells |
US7347869B2 (en) | 2003-10-31 | 2008-03-25 | Cordis Corporation | Implantable valvular prosthesis |
US7070616B2 (en) | 2003-10-31 | 2006-07-04 | Cordis Corporation | Implantable valvular prosthesis |
US7416530B2 (en) | 2003-11-04 | 2008-08-26 | L & P 100 Limited | Medical devices |
US7473274B2 (en) | 2003-11-12 | 2009-01-06 | Medtronic Vascular, Inc. | Coronary sinus approach for repair of mitral valve regurgitation |
JP2007510525A (en) | 2003-11-12 | 2007-04-26 | メドトロニック ヴァスキュラー インコーポレイテッド | Heart annulus reduction system |
US7740656B2 (en) | 2003-11-17 | 2010-06-22 | Medtronic, Inc. | Implantable heart valve prosthetic devices having intrinsically conductive polymers |
US20050143811A1 (en) | 2003-12-02 | 2005-06-30 | Fidel Realyvasquez | Methods and apparatus for mitral valve repair |
CA2552857A1 (en) | 2003-12-04 | 2005-06-23 | Brigham And Women's Hospital, Inc. | Aortic valve annuloplasty rings |
US7186265B2 (en) | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US20050177228A1 (en) | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
AU2004298762A1 (en) | 2003-12-16 | 2005-06-30 | Edwards Lifesciences Ag | Device for changing the shape of the mitral annulus |
US7794496B2 (en) | 2003-12-19 | 2010-09-14 | Cardiac Dimensions, Inc. | Tissue shaping device with integral connector and crimp |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20050137450A1 (en) | 2003-12-19 | 2005-06-23 | Cardiac Dimensions, Inc., A Washington Corporation | Tapered connector for tissue shaping device |
US7837728B2 (en) | 2003-12-19 | 2010-11-23 | Cardiac Dimensions, Inc. | Reduced length tissue shaping device |
US20050137449A1 (en) | 2003-12-19 | 2005-06-23 | Cardiac Dimensions, Inc. | Tissue shaping device with self-expanding anchors |
US7261732B2 (en) | 2003-12-22 | 2007-08-28 | Henri Justino | Stent mounted valve |
AU2003299404A1 (en) | 2003-12-23 | 2005-08-11 | Laboratoires Perouse | Kit which is intended to be implanted in a conduit |
US7381219B2 (en) * | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US20050137686A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7431726B2 (en) | 2003-12-23 | 2008-10-07 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137696A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Apparatus and methods for protecting against embolization during endovascular heart valve replacement |
US20050137691A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8603160B2 (en) * | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8840663B2 (en) * | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7748389B2 (en) * | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8182528B2 (en) * | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US20050149181A1 (en) | 2004-01-07 | 2005-07-07 | Medtronic, Inc. | Bileaflet prosthetic valve and method of manufacture |
WO2005069850A2 (en) | 2004-01-15 | 2005-08-04 | Macoviak John A | Trestle heart valve replacement |
US20050159810A1 (en) | 2004-01-15 | 2005-07-21 | Farzan Filsoufi | Devices and methods for repairing cardiac valves |
US7488346B2 (en) | 2004-01-21 | 2009-02-10 | The Cleveland Clinic Foundation | Method and apparatus for replacing a mitral valve and an aortic valve with a single homograft |
WO2005070342A1 (en) | 2004-01-22 | 2005-08-04 | Australian Surgical Design & Manufacture Pty Ltd | Heart valve |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
US7320705B2 (en) | 2004-01-23 | 2008-01-22 | James Quintessenza | Bicuspid pulmonary heart valve and method for making same |
US7597711B2 (en) | 2004-01-26 | 2009-10-06 | Arbor Surgical Technologies, Inc. | Heart valve assembly with slidable coupling connections |
DE602005019029D1 (en) | 2004-01-27 | 2010-03-11 | Med Inst Inc | RESISTANCE TO FIXING TO A MEDICAL PROSTHESIS |
AU2005213458B2 (en) | 2004-02-05 | 2010-04-22 | Children's Medical Center Corporation | Transcatheter delivery of a replacement heart valve |
US7311730B2 (en) | 2004-02-13 | 2007-12-25 | Shlomo Gabbay | Support apparatus and heart valve prosthesis for sutureless implantation |
WO2005082289A1 (en) | 2004-02-20 | 2005-09-09 | Cook Incorporated | Prosthetic valve with spacing member |
US7717930B2 (en) | 2004-02-27 | 2010-05-18 | Cook Incorporated | Valvulotome with a cutting edge |
US7785341B2 (en) | 2004-02-27 | 2010-08-31 | Aortx, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US20050203549A1 (en) | 2004-03-09 | 2005-09-15 | Fidel Realyvasquez | Methods and apparatus for off pump aortic valve replacement with a valve prosthesis |
EP3603576B1 (en) | 2004-03-11 | 2021-01-20 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
JP2007529273A (en) | 2004-03-15 | 2007-10-25 | メドトロニック ヴァスキュラー インコーポレイテッド | Stent resistant to radial crush |
WO2005087139A1 (en) | 2004-03-15 | 2005-09-22 | Baker Medical Research Institute | Treating valve failure |
US20050228494A1 (en) | 2004-03-29 | 2005-10-13 | Salvador Marquez | Controlled separation heart valve frame |
US7449027B2 (en) | 2004-03-29 | 2008-11-11 | Cook Incorporated | Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes |
US20060013855A1 (en) * | 2004-04-05 | 2006-01-19 | Medivas, Llc | Bioactive stents for type II diabetics and methods for use thereof |
US7993397B2 (en) | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
US20050222675A1 (en) | 2004-04-06 | 2005-10-06 | Sauter Joseph A | Implantable prosthetic heart valve comprising a valve body and a tubular vascular graft |
US8349001B2 (en) | 2004-04-07 | 2013-01-08 | Medtronic, Inc. | Pharmacological delivery implement for use with cardiac repair devices |
WO2005099628A2 (en) | 2004-04-13 | 2005-10-27 | Cook Incorporated | Implantable frame with variable compliance |
US20050240202A1 (en) | 2004-04-21 | 2005-10-27 | Hani Shennib | Devices and methods of repairing cardiac valves |
AU2005234793B2 (en) * | 2004-04-23 | 2012-01-19 | 3F Therapeutics, Inc. | Implantable prosthetic valve |
US20050240255A1 (en) | 2004-04-23 | 2005-10-27 | Schaeffer Darin G | Carrier-Based Delivery System for Intraluminal Medical Devices |
US7641686B2 (en) | 2004-04-23 | 2010-01-05 | Direct Flow Medical, Inc. | Percutaneous heart valve with stentless support |
US7951196B2 (en) | 2004-04-29 | 2011-05-31 | Edwards Lifesciences Corporation | Annuloplasty ring for mitral valve prolapse |
US20050244460A1 (en) | 2004-04-29 | 2005-11-03 | Ivan Alferiev | Biodegradable crosslinking strategies using triglycidyl amine (TGA) |
US7374573B2 (en) | 2004-05-03 | 2008-05-20 | Shlomo Gabbay | System and method for improving ventricular function |
US20050256566A1 (en) | 2004-05-03 | 2005-11-17 | Shlomo Gabbay | Apparatus and method for improving ventricular function |
WO2005107650A2 (en) * | 2004-05-05 | 2005-11-17 | Direct Flow Medical, Inc. | Unstented heart valve with formed in place support structure |
US7717951B2 (en) | 2004-05-06 | 2010-05-18 | Cook Incorporated | Delivery system that facilitates visual inspection of an intraluminal medical device |
US20060122692A1 (en) | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent valve and method of using same |
US20060095115A1 (en) | 2004-05-10 | 2006-05-04 | Youssef Bladillah | Stent and method of manufacturing same |
US20060122693A1 (en) | 2004-05-10 | 2006-06-08 | Youssef Biadillah | Stent valve and method of manufacturing same |
US20060122686A1 (en) | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent and method of manufacturing same |
WO2005112831A2 (en) | 2004-05-17 | 2005-12-01 | Fidel Realyvasquez | Method and apparatus for percutaneous valve repair |
US7803182B2 (en) | 2004-05-28 | 2010-09-28 | Cordis Corporation | Biodegradable vascular device with buffering agent |
WO2005118019A1 (en) | 2004-05-28 | 2005-12-15 | Cook Incorporated | Implantable bioabsorbable valve support frame |
US7785615B2 (en) | 2004-05-28 | 2010-08-31 | Cordis Corporation | Biodegradable medical implant with encapsulated buffering agent |
GB0414099D0 (en) | 2004-06-23 | 2004-07-28 | Univ Glasgow | Biocompatible layered structures and methods for their manufacture |
WO2006004679A1 (en) | 2004-06-29 | 2006-01-12 | The Cleveland Clinic Foundation | Prosthetic cardiac valve and method for making same |
US7510577B2 (en) | 2004-06-29 | 2009-03-31 | Micardia Corporation | Adjustable cardiac valve implant with ferromagnetic material |
US7276078B2 (en) | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
US7462191B2 (en) * | 2004-06-30 | 2008-12-09 | Edwards Lifesciences Pvt, Inc. | Device and method for assisting in the implantation of a prosthetic valve |
WO2006002492A1 (en) | 2004-07-06 | 2006-01-12 | Baker Medical Research Institute | Treating valvular insufficiency |
US7513864B2 (en) * | 2004-07-09 | 2009-04-07 | Kantrowitz Allen B | Synchronization system between aortic valve and cardiac assist device |
US7167746B2 (en) * | 2004-07-12 | 2007-01-23 | Ats Medical, Inc. | Anti-coagulation and demineralization system for conductive medical devices |
EP1768611A4 (en) * | 2004-07-15 | 2009-11-18 | Micardia Corp | Implants and methods for reshaping heart valves |
US8034102B2 (en) * | 2004-07-19 | 2011-10-11 | Coroneo, Inc. | Aortic annuloplasty ring |
US7422607B2 (en) | 2004-08-24 | 2008-09-09 | Oviatt Henry W | Anti-calcification treatments for heart valves and vascular grafts |
JP2008510587A (en) | 2004-08-26 | 2008-04-10 | クック インコーポレイテッド | Delivery device with controlled friction characteristics |
CA2578259A1 (en) | 2004-08-27 | 2006-03-09 | Cook Incorporated | Placement of multiple intraluminal medical devices within a body vessel |
JP4713589B2 (en) | 2004-09-01 | 2011-06-29 | クック インコーポレイテッド | Delivery system for hydration of intraluminal medical devices |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
FR2874813B1 (en) | 2004-09-07 | 2007-06-22 | Perouse Soc Par Actions Simpli | VALVULAR PROSTHESIS |
CN1745727A (en) | 2004-09-08 | 2006-03-15 | 王蓉珍 | Intercurrent artificial heart valve, its implanting and recovering device |
CA2579434A1 (en) | 2004-09-10 | 2006-03-23 | Cook Incorporated | Prosthetic valve with pores |
EP1796597B1 (en) | 2004-09-14 | 2013-01-09 | Edwards Lifesciences AG | Device for treatment of heart valve regurgitation |
WO2006034245A2 (en) | 2004-09-20 | 2006-03-30 | Cardiac Dimensions, Inc. | Percutaneous mitral valve annuloplasty delivery system |
US20060064174A1 (en) | 2004-09-22 | 2006-03-23 | Reza Zadno | Implantable valves and methods of making the same |
US7850704B2 (en) | 2004-09-27 | 2010-12-14 | Theranova, Llc | Method and apparatus for anchoring implants |
US6951571B1 (en) | 2004-09-30 | 2005-10-04 | Rohit Srivastava | Valve implanting device |
US20060074483A1 (en) | 2004-10-01 | 2006-04-06 | Schrayer Howard L | Method of treatment and devices for the treatment of left ventricular failure |
AU2005294316A1 (en) | 2004-10-06 | 2006-04-20 | Cook Incorporated | Medical device with bioactive agent |
US20060085060A1 (en) | 2004-10-15 | 2006-04-20 | Campbell Louis A | Methods and apparatus for coupling an allograft tissue valve and graft |
US7442206B2 (en) | 2004-10-28 | 2008-10-28 | Cook Incorporated | Methods and systems for modifying vascular valves |
US7458987B2 (en) | 2004-10-29 | 2008-12-02 | Cook Incorporated | Vascular valves having implanted and target configurations and methods of preparing the same |
US7641687B2 (en) | 2004-11-02 | 2010-01-05 | Carbomedics Inc. | Attachment of a sewing cuff to a heart valve |
US20080058652A1 (en) | 2004-11-04 | 2008-03-06 | Payne Peter A | Medical Devices |
US20060100697A1 (en) | 2004-11-10 | 2006-05-11 | Casanova R M | Shape memory annuloplasty ring and holder |
US20060167468A1 (en) | 2004-11-12 | 2006-07-27 | Shlomo Gabbay | Implantation system and method for loading an implanter with a prosthesis |
EP1830747A2 (en) | 2004-11-19 | 2007-09-12 | Medtronic, Inc. | Method and apparatus for treatment of cardiac valves |
US7744642B2 (en) | 2004-11-19 | 2010-06-29 | Biomedical Research Associates, Inc. | Prosthetic venous valves |
US20060161249A1 (en) | 2004-11-22 | 2006-07-20 | Fidel Realyvasquez | Ring-shaped valve prosthesis attachment device |
US20060135967A1 (en) | 2004-11-22 | 2006-06-22 | Fidel Realyvasquez | Method and apparatus for attaching a valve prosthesis |
US20060111774A1 (en) | 2004-11-24 | 2006-05-25 | Samkov Alexander V | Low noise heart valve prosthesis and method for operation |
US20060116572A1 (en) | 2004-12-01 | 2006-06-01 | Case Brian C | Sensing delivery system for intraluminal medical devices |
WO2006060546A2 (en) | 2004-12-01 | 2006-06-08 | Cook Incorporated | Valve with leak path |
WO2006063181A1 (en) | 2004-12-06 | 2006-06-15 | Surmodics, Inc. | Multifunctional medical articles |
US20060127443A1 (en) | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
US7211110B2 (en) | 2004-12-09 | 2007-05-01 | Edwards Lifesciences Corporation | Diagnostic kit to assist with heart valve annulus adjustment |
CN101076290B (en) | 2004-12-09 | 2011-11-23 | 铸造品股份有限公司 | Aortic valve repair |
US7410497B2 (en) | 2004-12-14 | 2008-08-12 | Boston Scientific Scimed, Inc. | Stimulation of cell growth at implant surfaces |
WO2006064490A1 (en) | 2004-12-15 | 2006-06-22 | Mednua Limited | A medical device suitable for use in treatment of a valve |
SE0403046D0 (en) | 2004-12-15 | 2004-12-15 | Medtentia Ab | A device and method for improving the function of a heart valve |
US20060217802A1 (en) | 2004-12-16 | 2006-09-28 | Carlos Ruiz | Heart valve and method for insertion of the heart valve into a bodily vessel |
JP2008523923A (en) | 2004-12-16 | 2008-07-10 | ルイス,カルロス | Separable sheath and method for inserting medical device into body tube using separable sheath |
US7758640B2 (en) | 2004-12-16 | 2010-07-20 | Valvexchange Inc. | Cardiovascular valve assembly |
US7544205B2 (en) | 2004-12-20 | 2009-06-09 | Cook Incorporated | Intraluminal support frame and medical devices including the support frame |
US7575594B2 (en) | 2004-12-30 | 2009-08-18 | Sieracki Jeffrey M | Shock dampening biocompatible valve |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US7854755B2 (en) * | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US8747458B2 (en) * | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
ES2400494T3 (en) * | 2008-02-29 | 2013-04-10 | Edwards Lifesciences Corporation | Expandable element to deploy a prosthetic device |
-
2005
- 2005-02-01 US US11/049,019 patent/US20060173490A1/en not_active Abandoned
-
2006
- 2006-01-06 WO PCT/US2006/000230 patent/WO2006083472A1/en active Application Filing
- 2006-01-06 EP EP12179239.4A patent/EP2537486B1/en not_active Not-in-force
- 2006-01-06 EP EP06717435.9A patent/EP1855614B1/en not_active Not-in-force
- 2006-01-06 CA CA002596296A patent/CA2596296A1/en not_active Abandoned
- 2006-01-06 EP EP17173267.0A patent/EP3245978A1/en not_active Withdrawn
- 2006-01-06 JP JP2007554096A patent/JP4991572B2/en not_active Expired - Fee Related
-
2015
- 2015-01-23 US US14/604,125 patent/US9622859B2/en not_active Expired - Fee Related
-
2016
- 2016-09-06 US US15/257,498 patent/US20160374793A1/en not_active Abandoned
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3983581A (en) * | 1975-01-20 | 1976-10-05 | William W. Angell | Heart valve stent |
US5300086A (en) * | 1990-01-19 | 1994-04-05 | Pierre Gory | Device with a locating member for removably implanting a blood filter in a vein of the human body |
US20030065356A1 (en) * | 1997-05-08 | 2003-04-03 | Embol-X, Inc. | Methods of protecting a patient from embolization during surgery |
US20050010285A1 (en) * | 1999-01-27 | 2005-01-13 | Lambrecht Gregory H. | Cardiac valve procedure methods and devices |
US20020151970A1 (en) * | 1999-02-10 | 2002-10-17 | Garrison Michi E. | Methods and devices for implanting cardiac valves |
US6235044B1 (en) * | 1999-08-04 | 2001-05-22 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US20050015112A1 (en) * | 2000-01-27 | 2005-01-20 | Cohn William E. | Cardiac valve procedure methods and devices |
US6692513B2 (en) * | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US6582448B1 (en) * | 2000-12-21 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Vessel occlusion device for embolic protection system |
US20100168836A1 (en) * | 2003-02-21 | 2010-07-01 | Kassab Ghassan S | Balloon sizing of valve annulus for percutaneous valves |
US20050075662A1 (en) * | 2003-07-18 | 2005-04-07 | Wesley Pedersen | Valvuloplasty catheter |
US20050187616A1 (en) * | 2003-11-13 | 2005-08-25 | Fidel Realyvasquez | Methods and apparatus for valve repair |
US20050137676A1 (en) * | 2003-12-19 | 2005-06-23 | Scimed Life Systems, Inc. | Venous valve apparatus, system, and method |
US20050137697A1 (en) * | 2003-12-23 | 2005-06-23 | Amr Salahieh | Leaflet engagement elements and methods for use thereof |
US7959666B2 (en) * | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7988724B2 (en) * | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US20050240200A1 (en) * | 2004-04-23 | 2005-10-27 | Bjarne Bergheim | Method and system for cardiac valve delivery |
US20060074484A1 (en) * | 2004-10-02 | 2006-04-06 | Huber Christoph H | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
US20060136043A1 (en) * | 2004-12-22 | 2006-06-22 | Cully Edward H | Filament-wound implantable devices |
US8012198B2 (en) * | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US20080269877A1 (en) * | 2007-02-05 | 2008-10-30 | Jenson Mark L | Systems and methods for valve delivery |
US20100131056A1 (en) * | 2007-05-02 | 2010-05-27 | Lapeyre Industries Llc | Mechanical prosthetic heart valve |
US20100305604A1 (en) * | 2007-11-27 | 2010-12-02 | Gunnar Pah | Device for Filtering Blood |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9987133B2 (en) | 2008-02-26 | 2018-06-05 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US10702382B2 (en) | 2008-02-26 | 2020-07-07 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US10154901B2 (en) | 2008-02-26 | 2018-12-18 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
Also Published As
Publication number | Publication date |
---|---|
EP2537486A1 (en) | 2012-12-26 |
EP1855614A1 (en) | 2007-11-21 |
US20060173490A1 (en) | 2006-08-03 |
JP2008528232A (en) | 2008-07-31 |
US20150142102A1 (en) | 2015-05-21 |
US9622859B2 (en) | 2017-04-18 |
EP1855614B1 (en) | 2017-05-31 |
EP3245978A1 (en) | 2017-11-22 |
CA2596296A1 (en) | 2006-08-10 |
EP2537486B1 (en) | 2020-08-19 |
JP4991572B2 (en) | 2012-08-01 |
WO2006083472A1 (en) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9622859B2 (en) | Filter system and method | |
US7854755B2 (en) | Vascular catheter, system, and method | |
US20200030089A1 (en) | Stents for Prosthetic Heart Valves | |
US8002824B2 (en) | Cardiac valve, system, and method | |
US8721717B2 (en) | Venous valve apparatus, system, and method | |
EP1945141B1 (en) | Venous valve, system, and method with sinus pocket | |
US20080269877A1 (en) | Systems and methods for valve delivery | |
WO2008097589A1 (en) | Percutaneous valve, system, and method | |
EP4378420A2 (en) | Stents for prosthetic heart valves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |